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Abstract 
 
The cellular radiosensitivity of two fibroblast cell lines derived from a breast cancer 
patient that “over-reacted” to radiotherapy (84BR) and a patient with multiple 
independent tumours (175BR) was examined. Both patients had not been previously 
diagnosed with a mutation in any known DNA repair gene. 
 
The clonogenic assay revealed the 84BR and 175BR cell lines were hypersensitive 
to gamma radiation when compared to repair normal NB1 and 1BR.3 fibroblast cells. 
In addition, DNA DSB repair was found to be defective in both patient cell lines due 
to the abnormal persistence of -H2AX foci over a 24 hour time point in the nuclei of 
gamma irradiated cells when compared to normal fibroblasts. Also  normal response 
to the cross-linking agent nitrogen mustard in a clonogenic assay was observed in 
84BR and 175BR cell lines indicating a normal homologous recombination (HR) DNA 
repair pathway (since HR is essential for DNA crosslink repair). From these data it 
was concluded that these cells were defective in one or more components of the Non 
Homologous End Joining (NHEJ) pathway.  
 
The Artemis gene which has an endonuclease activity in the NHEJ repair pathway 
trims the ends of the double strand breaks before the two ends are ligated. 
Quantitative real time PCR analysis detected approximately 1.5 to 2 fold over-
expression in Artemis gene in 84BR and 175BR cell lines compared to normal cells.  
Also an increase in the level of apoptosis before and following radiation exposure 
and a failure to efficiently repair DNA DSB were observed in the patient cell lines. 
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Consequently, it was demonstrated in the cell lines described in this study that 
increased expression of Artemis endonuclease leads to abnormal and illegitimate 
DNA DSBs due to unregulated action of the protein thus, contributing to increased 
radiosensitivity and elevated apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
Publications 
 
1. Elevated expression of Artemis in human fibroblast cells is associated with 
cellular radiosensitivity and increased apoptosis. G Ulus-Senguloglu, CF 
Arlett, PN Plowman, J Parnell, N Patel, EC Bourton and CN Parris. British 
Journal of Cancer (2012) 107, 1506–1513. 2012. 
 
 
2. Multispectral imaging flow cytometry reveals distinct frequencies of γ-H2AX 
foci induction in DNA double strand break repair defective human cell lines. 
Emma C. Bourton, Piers N. Plowman, Sheba Adam Zahir, Gonul Ulus-
Senguloglu, Hiba Serrai, Graham Bottley, Christopher N. Parris, Cytometry 
Part A,  Volume 81A, Issue 2, pg. 130-137, 2012. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
Acknowledgement 
I would like to express my sincere gratitude towards my supervisor Dr. Christopher 
Parris for his guidance, support and understanding especially during my pregnancy. 
His supervision was paramount for the completion of this project. I must extend my 
thanks to my group members, Hiba, Sheba and Dr. Emma Bourton for being an 
excellent team. 
 
In addition, some members of the Institute have been very kind to extend their help 
at various phases of my research, so I want to thank Dr. Sahar Al-Mahdawi, Dr. 
Chiranjeevi Sandi and Dr. Rana Hassan on various helpful discussions, guidance 
and moral support, Dr. Hemad Yasaei and Dr. Terry Roberts for their valuable 
suggestions with quantitative PCR and Dr. Evgeny Makarov for his professional 
support during my pregnancy. 
 
I like to thank all my friends Dr. Mengya Liu, Dr. Aycan Cinar, Maryam, Punam, 
Azadeh, Vahid, Yaghoub, Seda, Hassan, Chetana and Ane, for being great friends 
during my research. 
 
I want to thank my husband, Mustafa Hayri, for his love, support, encouragement and 
patience which were undeniably the only drive that kept me going throughout my 
research.  In addition, I want to extend my gratitude towards my in-laws. Finally, and 
most importantly, I would like to say a ‘big thank you’ to my beautiful daughter, Ezo 
Dilara, for putting a smile on my face every day.  
 
Last but not the least, I want to humbly thank my parents Suleyman and Elif,  and my 
dearest sister Belgin, for their faith in me and allowing me to be as ambitious as I 
want to be. It was under their watchful eye, especially from my mother, that I gained 
so much drive and an ability to tackle challenges head on. For these reasons and 
more, I would like to dedicate this project to my lovely mother.  
 
 
 
 
vi 
 
Table of contents 
 
Abstract ....................................................................................................................... ii 
Publications ................................................................................................................ iv 
Acknowledgement ....................................................................................................... v 
Table of contents ........................................................................................................ vi 
List of Figures .............................................................................................................. x 
List of Tables ............................................................................................................. xii 
Abbreviations ........................................................................................................... xiii 
Chapter 1 - General Introduction ............................................................................... 1 
1.1 - DNA damage and repair ............................................................................ 1 
1.1.1 - Direct repair (DR) ................................................................................ 4 
1.1.2 - Base Excision repair (BER) ................................................................. 6 
1.1.3 - Nucleotide excision repair (NER) ........................................................ 9 
1.1.4 - Mismatch repair (MMR) ......................................................................11 
1.2 - DNA Strand breaks ...................................................................................14 
1.2.1 - DSBs initiated by Oxidative Damage ..................................................15 
1.2.2 - DSBs initiation in B and T cell development .......................................19 
1.3 - DSB repair mechanisms ...........................................................................20 
1.3.1 - Non-Homologous End Joining (NHEJ) Pathway ................................20 
1.3.1.1 - Ku Heterodimer ...............................................................................23 
1.3.1.2 - DNA-Dependent Protein Kinase (DNA-PK) .....................................25 
1.3.1.3 - Artemis ............................................................................................26 
1.3.1.4 - XRCC4, XLF and DNA Ligase IV complex ......................................29 
1.3.2 - Homologous Recombination (HR) Pathway .......................................31 
1.3.3 - Single-Strand Annealing (SSA) ..........................................................33 
1.4 - Radiosensitivity and human syndromes ....................................................36 
1.4.1 - RS-SCID ............................................................................................37 
1.4.2 - Ataxia Telangiectasia (A-T) ................................................................39 
1.4.3 - Nijmegen Breakage syndrome (NBS) ................................................41 
1.4.4 - Bloom’s Syndrome (BS) .....................................................................43 
1.5 - Over responders to radiotherapy ..............................................................44 
1.5.1 - 84BR and 175BR Patients .................................................................46 
1.6 - Project Aim ...............................................................................................49 
Chapter 2 - Clonogenic assays ................................................................................50 
2.1 - Introduction ...............................................................................................50 
2.2 - Materials and Method ...............................................................................55 
vii 
 
2.2.1 - Cell Lines ...........................................................................................55 
2.2.2 - Cell Culture.........................................................................................55 
2.2.3 - Sub-culturing ......................................................................................56 
2.2.4 - Cell Count ..........................................................................................56 
2.2.5 - Irradiation of cells ...............................................................................57 
2.2.6 - Feeder Layers ....................................................................................57 
2.2.7 - Clonogenic Cell Survival Assay with Gamma Radiation .....................58 
2.2.8 - Clonogenic cell survival assay with Nitrogen Mustard ........................58 
2.3 - Results ......................................................................................................60 
2.3.1 - Clonogenic cell survival assays - Gamma Radiation ..........................60 
2.3.2 - Clonogenic cell survival assays - Nitrogen Mustard ...........................63 
2.4 - Discussion ................................................................................................66 
Chapter 3 - DNA DSB Assay (γ-H2AX detection) .....................................................68 
3.1 - Introduction ...............................................................................................68 
3.1.1 - Techniques employed for the measurement of DNA DSBs ................71 
3.2 - Materials & Method ...................................................................................77 
3.2.1 - Irradiation of cells ...............................................................................77 
3.2.2 - Fixing of cells......................................................................................77 
3.2.3 - Permeabilisation and Blocking ...........................................................77 
3.2.4 - Immunostaning with Anti-γH2AX Antibody .........................................77 
3.2.5 - Mounting Slides ..................................................................................78 
3.2.6 - Cell Scoring and Imaging ...................................................................78 
3.3 - Results ......................................................................................................79 
3.3.1 - -H2AX foci assay: DNA DSB repair ....................................................79 
3.4 - Discussion ................................................................................................82 
Chapter 4 - Quantification of NHEJ genes in radiosensitive cells by qRT-PCR ........84 
4.1 - Introduction ...............................................................................................84 
4.2 - Materials & Method ...................................................................................89 
4.2.1 - RNA Extraction ...................................................................................89 
4.2.1.1 - Cell Lysis .........................................................................................89 
4.2.1.2 - Phase Separation............................................................................89 
4.2.1.3 - RNA Precipitation ............................................................................90 
4.2.1.4 - RNA Wash and Re-suspension ......................................................90 
4.2.2 - RNA Concentration and Purity Detection ...........................................91 
4.2.3 - Deoxyribonuclease I, amplification grade treatment of RNA ..............91 
4.2.4 - cDNA Preparation ..............................................................................92 
viii 
 
4.2.4.1 - Annealing of Primers to RNA ..........................................................92 
4.2.4.2 - Synthesis of First Strand cDNA .......................................................92 
4.2.4.3 - Determining the quality of cDNA .....................................................92 
4.2.5 - Determining the quality of primers ......................................................93 
4.2.6 - Determining the quality of PCR products ...........................................94 
4.2.7 - Designing Primers for NHEJ repair genes ..........................................94 
4.2.8 - Optimising Primer Concentration ........................................................96 
4.2.9 - qRT-PCR ............................................................................................96 
4.2.10 - qRT-PCR data analysis on SDS.3 Software ......................................97 
4.2.11 - Setting up the Dissociation Program ..................................................98 
4.3 - Results ......................................................................................................99 
4.4 - Discussion ..............................................................................................109 
Chapter 5 - Artemis over-expression and Apoptosis in Radiosensitive cells ..........111 
5.1 - Introduction .............................................................................................111 
5.2 - Materials and Method .............................................................................113 
5.2.1- Transfection of NB1-Tert cells with Artemis cDNA ..............................113 
5.2.2- Maxi Preparation of Plasmid DNA .......................................................115 
5.2.2.1 - Transformation of E.coli ................................................................115 
5.2.2.2 - Growing Large Volume of Transformed Bacteria ..........................116 
5.2.2.3 - Purification of Plasmid DNA ..........................................................116 
5.2.3- Analysis of Purified Plasmid DNA ........................................................118 
5.2.4- Agarose Gel Analysis of Purified Plasmid DNA ...................................118 
5.2.5- Co-transfection of NB1-Tert cells with pCMV6-XL5 Artemis cDNA .....119 
5.2.6- Isolation and Freezing of NB1-Tert Transfectants ...............................119 
5.2.7- Clonogenic assay – Surviving fraction at 2 Gy gamma irradiation .......119 
5.2.8- Quantitation of Artemis Protein Expression in Cells ............................120 
5.2.9- Apoptosis Assay ..................................................................................121 
5.2.10- Sample loading and data analysis ....................................................121 
5.3 - Results ....................................................................................................122 
5.3.1 - Detection of plasmid Quality with Agarose gel .................................123 
5.3.2 - Artemis Expression in Cells ..............................................................123 
5.3.3 - Radiation Sensitivity of Artemis Transfected NB1-Tert Cells ............126 
5.3.4 - Elevated Apoptosis in Artemis Transfected NB1-Tert Cells .............128 
5.3.5 - Apoptosis in radiation hypersensitive patient cells ...........................130 
5.4 - Discussion ..............................................................................................133 
Chapter 6 - General Discussion .............................................................................136 
ix 
 
Future Work ............................................................................................................141 
References ..............................................................................................................143 
Appendix .................................................................................................................154 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
List of Figures 
Figure 1.1   - Repair of O6 alkylguanine adducts by MGMT………… 5 
Figure 1.2   - Model for BER pathway…………………………………. 8 
Figure 1.3   - Model for NER pathway…………………………………. 10 
Figure 1.4   - Human MMR……………………………………………… 13 
Figure 1.5   - Main steps involved in NHEJ…………………………… 22 
Figure 1.6   -  
Binding and bridging of DNA ends through Ku 
heterodimers……………………………………………... 
24 
Figure 1.7   - DNA-PK and Artemis mediated DNA end processing.. 28 
Figure 1.8   - Main steps involved in HR………………………………. 32 
Figure 1.9   - SSA model for repair of a two-ended DNA DSB……… 34 
Figure 1.10 - Cancer Prone Kindred…………………………………… 48 
Figure 2.1   - 
Sensitivity of 84BR and 175BR to IR Compare to Control 
Cell Lines………………………………………… 
 
61 
Figure 2.2   - 
Sensitivity of 84BR and 175BR to HN2 Compare to Control 
Cell Lines………………………………………… 
 
64 
Figure 3.1   - Chromatin structure and histone-modifying enzymes.. 69 
Figure 3.2   - 
Imagestream analysis of Gamma-H2AX foci in human 
cells………………………………………………………... 
 
73 
Figure 3.3   - 
Fluorescence microscopy visualisation of comet 
assay……………………………………………………... 
 
74 
Figure 3.4   - A model for PFGE……………………………………….. 75 
Figure 3.5   - 
DSB repair measured by formation and disappearance of 
-H2AX foci in radiosensitive cells and 
controls………………………………………………. 
 
 
80 
Figure 4.1   - Steps in nucleic acid quantification by real time PCR.. 86 
Figure 4.2   - 
Total RNA for NB1, 1BR.3, 84BR and 175BR 
samples........................................................................ 
 
100 
Figure 4.3   - cDNA samples for GAPDH in patient and control cells 101 
Figure 4.4   - Primers at 10µM concentration………………………… 102 
xi 
 
Figure 4.5   - 
Melting curve showing the primer dimer with GAPDH at 
10µM concentration…………………………………... 
 
103 
Figure 4.6   - Primers run at 10µM concentration on 1% agarose gel  104 
Figure 4.7   - 
GAPDH run at 5µM and remaining primers run at 10µM 
concentration……………………………………… 
 
105 
Figure 4.8   - 
NHEJ gene expression in 84BR radiosensitive 
fibroblasts…………………………………………………. 
 
106 
Figure 4.9   - 
NHEJ gene expression in 175BR radiosensitive 
fibroblasts…………………………………………………. 
 
107 
Figure 5.1   - Map of pCMV6-XL5……………………………………… 113 
Figure 5.2   - Map of Plasmid pPur…………………………………….. 114 
Figure 5.3   - Agarose gel analysis of the purified plasmids………… 123 
Figure 5.4   - 
Representative images of NB1-Tert cells stained for 
Artemis……………………………………………………. 
 
126 
Figure 5.5   - The -radiation sensitivity of Artemis transfectants… 127 
Figure 5.6   - 
Apoptosis in the NB1-Tert cells transfected to over- 
express the Artemis protein…………………………….. 
 
128 
Figure 5.7   - 
Non-apoptotic and cells at different stages of 
apoptosis………………………………………………….. 
 
129 
Figure 5.8   - Apoptosis in patient and in control cells……………….. 131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
List of Tables  
Table 1.1  - 
Principal of DNA-damaging agents, lesions & repair 
pathways……………………………………………………… 
 
2 
Table 1.2  - 
Review of DNA repair genes and their activity in DNA 
repair………………………………………………………….. 
 
3 
Table 1.3  - Radiosensitivity associated disorders……………………... 36 
Table 1.4  - NTT (Skin) following radiotherapy…………………………. 44 
Table 2.1  - 
The Dose of radiation required to reduce cell survival in a 
clonogenic assay to 10% (D10) in patient and control 
cells……………………………………………………………. 
 
 
62 
Table 3.1  - 
The -H2AX foci formation following 2Gy of gamma irradiation 
in irradiated patient and control cells…………. 
 
81 
Table 4.1  - 
NHEJ repair genes and their locations on different 
chromosomes……………………………………………….. 
 
85 
Table 4.2  - PCR amplification cycles for detection of cDNA quality… 93 
Table 4.3  - PCR amplification cycles for detection of primer quality... 93 
Table 4.4  - 
Primer sequences used for the amplification of NHEJ genes 
during qRT-PCR analysis……………………….. … 
95 
Table 4.5  - PCR reaction conducted at 10µM primer concentration... 96 
Table 4.6  - The thermal profile set for the qRT-PCR reaction……….. 97 
Table 4.7  - The thermal profile set for the dissociation curve……….. 98 
Table 5.1  - 
Artemis expression in all cell lines determined by imaging flow 
cytometry…………………………………....... 
 
124 
 
 
 
 
 
 
 
 
 
xiii 
 
Abbreviations 
 
AB   Applied Biosystems  
ALL    Acute lymphoblastic leukemia 
ALS    Alkali site  
AP   Apurinic/apyrimidinic  
APE1   AP endonuclease 1 
A-T   Ataxia telangiectasia 
ATM   Ataxia telangiectasia-mutated  
ATR    Ataxia and Rad3 related 
BER   Base excision repair 
BRCA1  Breast cancer associated gene 1 
BRCA2  Breast cancer associated gene 2 
BRCT   BRCA1 COOH-terminal domain  
BS   Bloom’s syndrome 
CO2   Carbon dioxide 
cDNA   Complementary DNA 
CS    Cockayne syndrome  
CFA    Colony forming assay  
CCD   Cooled charge-coupled device  
CMP   Common myeloid progenitor 
Ct    Cycle threshold  
CPD     Cyclobutane pyrimidine dimer 
CMV   Cytomegalovirus 
DRAQ5  Deep red fluorescing bisalkylaminoanthraquinone  
DAPI   4’6-diamidino-2 phenylindole  
DNA    Deoxyribonucleic acid 
DNA SSB  DNA single strand break 
dRP   Deoxyribophosphate  
DSB    Double strand break 
DEPC   Diethyl pyrocarbonate 
DMSO  Dimethylsulphoxide 
DR    Direct repair  
DDR    DNA damage response 
xiv 
 
DNA-PK   DNA-dependent protein kinase 
DNA-PKcs   DNA-protein kinase catalytic-subunit 
DMEM  Dulbecco modified eagle medium 
dsDNA  Double strand DNA 
D10    Dose, required to reduce colony survival to 10% 
EBV    Epstein-Barr virus  
E.coli    Escherichia coli  
EtBr   Ethidium bromide 
EDTA   Ethylene-diamine-tetra-acetic-acid  
ERCC   Excision repair cross complementing 
FISH    Fluorescence in-situ hybridisation 
FEN-1   Flap structure-specific endonuclease 1  
Gy    Gray 
GG-NER   Global genome nucleotide excision repair  
GAPDH   Glyceraldehyde-3-phosphate dehydrogenase  
GMP    Granulocyte/macrophage progenitors  
IC50   Half maximal inhibitory concentration  
HTH    Helix turn helix  
HNPCC   Hereditary non-polyposis colorectal cancer 
HBV    Hepatitis B virus  
HSPC   Hematopoietic stem cell 
HCA   Heterocyclic amine 
HR    Homologous recombination 
OH   Hydroxyl 
H2O2    Hydrogen peroxide  
HPV    Human papilloma virus  
hTERT   Human telomerase reverse transcriptase  
oh'Gua   8-hydroxyguanine  
IR    Ionising radiation 
ICL    Interstrand cross link 
IMS   Industrial methylated spirit 
LENT SOMA Late effects in normal tissues subjective, objective, management 
and analytic scale  
LMDS  Locally multiple damaged sites  
xv 
 
LET    Linear Energy Transfer  
LB   Luria-Bertani  
mTOR  Mammalian target of rapamycin 
CH3-   Methyl group  
D0    Mean lethal radiation dose 
MGMT   Methylguanine-DNA metyl-transferase  
MLPA   Multiplex ligation-dependent probe amplification  
MSH   MutS homologue  
MTT   3-(4,5-dimethylthylthiazol-2-yl)-2,5-dithenyltetrazolium 
MAC   Multiple cloning site 
MMR   Mismatch repair  
NCBI   National Centre for Biotechnology Information  
NOC    N-nitroso compounds  
NHEJ    Non-homologous end joining 
NO2    Nitrogen dioxide radical  
HN2   Nitrogen mustard  
NBS   Nijmegen Breakage Syndrome 
NTT   Normal tissue toxicity  
NTC   Non template control 
NER   Nucleotide excision repair 
ONOO−   Peroxynitrite anion  
PBS    Phosphate buffer saline 
6-4PPs   Photoproducts  
PIKK    Phosphatidylinositol-3-kinase 
PE    Plating efficiency 
Pol β    Polymerase β  
PCR    Polymerase chain reaction 
PCNA   Proliferating cell nuclear antigen  
PFGE   Pulsed field gel electrophoresis  
qRT-PCR  Quantitative real time PCR 
RDS    Radio- resistant DNA synthesis  
RT    Radiotherapy  
RS-SCID  Radiosensitive severe-combined immunodeficiency  
RTOG   Radiotherapy oncology group  
xvi 
 
RAG    Recombinase activating gene  
ROS    Reactive oxygen species  
RFC    Replication factor C  
RPLD   Repair of potentially lethal damage 
RPA    Replication protein A  
Rpm   Revolutions per minute 
RNS    Reactive nitrogen species  
RNA    Ribonucleic acid 
RNAPII  RNA polymerase II  
SCID   Severe-combined immunodeficiency 
SDS   Sequence Detection System  
SSB    Single strand break 
SSA    Single strand annealing 
SCGE   Single-cell gel electrophoresis  
ssDNA   Single strand DNA 
SDS    Sodium dodecyl sulphate 
SD    Standard deviation 
SE   Standard error 
SEM    Standard error of mean 
SMG-1  Suppressor of morphogenesis in genitalia 1 
SRB    Sulforhodamine B  
TFIIH   Transcription factor IIH 
TCR   T cell receptor 
TC-NER   Transcription-coupled nucleotide excision repair  
TRRAP   Transformation/transcription domain-associated protein  
TBS    Tris buffered saline  
UV    Ultra violet 
V (D) J   Variable (diversity) joining  
XP   Xeroderma pigmentosum 
WS    Werner syndrome  
XRCC4  X-ray cross complementing 4 
XLF    XRCC4 like factor  
XP   Xeroderma Pigmentosum
1 
 
Chapter 1 - General Introduction 
 
1.1 - DNA damage and repair 
To achieve a successful flow of genetic information from DNA, genetic stability and 
physical integrity of the DNA must be protected from DNA damaging agents. 
Although the DNA is a stable molecule and has sophisticated DNA repair systems to 
protect it from DNA damaging agents, the DNA is subject to exposure by exogenous 
or endogenous damage at all times which cause damage. The modifications made 
within the DNA, unlike some molecules such as, proteins and lipids where the 
damage is readily degraded and resynthesized, is permanent via the formation of 
mutations (Bohr and Dianov 1999). Although, all DNA lesions pose a threat to 
genetic integrity, DNA double strand breaks (DSBs) are considered especially 
deleterious as they can be potentially lethal if not repaired (Weterings and van Gent 
2004). Also as Tauchi et al., (2002), states even one DSB generated in a cell, if not 
successfully re-joined, can potentially result in cellular lethality.  
 
Some of the main exogenously occurring DNA damaging agents have been well 
characterised. These are ultra violet (UV) light, ionising radiation (IR), aflatoxins (a 
strongly carcinogenic mould produced contaminant) found in contaminated peanuts, 
hetrocyclic amines (HCA) in over-cooked meats, N-nitroso compounds (NOC) found 
in tobacco (Wogan et al., 2004; Jackson and Bartek 2009). The endogenous DNA 
damaging agents are reactive oxygen species (ROS), which are produced by normal 
oxidative metabolism and cause DNA base modification and strand breaks (reviewed 
in Valko et al., 2007)  
 
2 
 
However, depending on the type of DNA damage, the cells have evolutionary 
conserved specific DNA damage recognition and repair mechanisms that are 
activated and put into action for the repair of vast number of DNA damage. Some of 
the most common DNA damaging agents, the types of DNA lesions introduced and 
the specific DNA damage repair pathways are summarised in Table 1.1. 
 
Table 1.1 - Principal of DNA-damaging agents, lesions & repair pathways. 
 
Damaging Agent DNA Lesion 
Repair 
Pathway 
IR 
Anti-tumour agents 
DSBs 
HR  
NHEJ 
Spontaneous reactions 
Oxygen radicals 
Alkylating agents 
X-rays 
Abasic site 
Oxidised deaminated and 
alkylated bases 
ssDNA breaks 
BER 
UV light 
6-4 photoproduct 
Cyclobutane pyrimidine dimer  
Bulky adduct 
NER 
Replication and recombination 
errors 
Base mismatches 
Insertion 
Deletion 
MMR 
 
HR, Homologous Recombination; NHEJ, Non-homologous End Joining; BER, Base Excision Repair; 
NER, Nucleotide Excision Repair; MMR, Mismatch Repair (Scharer 2003). 
 
 
As mentioned, depending on the type, extent and the location of the DNA damage, 
specific DNA repair mechanisms are activated within the cell to recognise, signal and 
repair the DNA damage. This distinctive nature of the DNA repair is gained through 
the presence of more than a hundred DNA repair genes whose proteins are 
equipped with different functions in the DNA repair process. Some of these DNA 
repair genes discovered since 2001 are illustrated in Table 1.2. 
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Table 1.2 - Review of DNA repair genes and their activity in DNA repair. 
DNA repair 
Mechanisms 
DNA 
repair genes 
Activity References 
NHEJ 
Ku70 & Ku80 
DNA-PKcs 
Artemis 
XRCC4 & XLF 
Ligase IV 
Non-specific dsDNA end binding 
Bridging of the DNA ends 
Trimming of the DNA ends 
Processing and gap filling 
Sealing the nick and repair break 
(Hefferin 
and 
Tomkinson 
2005) 
 
HR 
RAD50 
RAD51 & RAD54 
RAD52 
BRCA1 & BRCA2 
Mre1 
Form a nuclease complex 
Required for homologous pairing 
Enhance the activity of RAD51 
Recruits repair proteins to DNA damage site 
Forms a nuclease complex with Rad50 & NBS1 
(Krejci et 
al., 2012) 
Direct repair MGMT O
6
-meG alkyltransferase 
(Hegi et al., 
2008) 
MMR 
MutSα & MutLα 
EXO1 
RPA 
PCNA 
RFC 
Pol δ 
DNA Ligase 
Binds mismatches 
Coordinates multiple steps in MMR 
Performs 3’-5’ excision of ssDNA 
Activated by MutSα 
Stabilises single-stranded gap 
DNA repair synthesis 
Seals the nick to complete the repair 
(Jiricny 
2006; Hsieh 
and 
Yamane 
2008)  
 
NER 
XPC-hHR23B 
XPB & XPD 
XPA 
XPG,XPF,ERCC1 
DNA Pol ɛ δ, 
PCNA, RPA, RCF 
Involved in damage recognition 
Promotes bubble formation 
Directs recruitment of other NER proteins 
Excises the damaged strand 
Excises and restores the nucleotide gap - 
generated by XPG,ERCC1,XPF 
(Friedberg 
2001) 
BER 
Glycosylase  
APE1 
Pol β, polδ/ɛ 
Ligase III/Ligase I 
XRCC1 
FEN1 
Recognises and removes damaged bases 
Targets AP sites & creates a 5’dRP group 
Fills the gap by adding nucleotide in the gap 
Seals the DNA ends 
Seals the DNA ends 
Removes the flap structure 
(Dianov et 
al., 1998) 
 
ERCC1, excision repair cross-complementing 1; PCNA, proliferating cell nuclear antigen; POL, 
polymerase; RFC, replication factor C; RPA, replication protein A; TFIIH, transcription factor IIH; XP, 
xeroderma pigmentosum; APE1, apurinic endoduclease 1; XRCC1, X-ray repair cross-complementing 
group 1; FEN 1, flap endonuclease 1, EXO1, Exonuclease 1; AP, apurinic/ apyrimidinic, BRCA 1, 
Breast cancer associated gene 1; BRCA 2, Breast cancer associated gene 2; XRCC4, X-ray cross 
complementing 4; XLF, XRCC4 like factor, MGMT, Methylguanine-DNA methyl-transferase.  
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1.1.1 - Direct repair (DR) 
The alkylating agents (e.g. methylating and chloroethylating anticancer drugs) or 
naturally occurring metabolic processes damage cellular macromolecules of DNA via 
a unimolecular nucleophilic substitution reaction (SN1 reaction) and thus, have a 
strong affinity towards oxygen atoms in DNA (Kaina et al., 2010). The SN1 reaction is 
where a functional group in a reaction is replaced by another group, so in this case 
the oxygen group in guanine, which is biologically most important position (Kaina et 
al., 2010), may be substituted with O6-alkylating agents such as; methyl group (CH3-) 
(inserted by methylating agents) or chloroethyl group (inserted by chloroethylating 
agent) at the O6 position of guanine. Both of these adducts are directly repaired by 
the suicide enzyme, O6-methylguanine-DNA metyl-transferase (MGMT). This DNA 
repair process is a single step reaction which involves direct reversal of the DNA 
damage into original form. The MGMT specifically removes the CH3 group from the 
O6 position of guanine, thereby restoring the nucleotide to its native form without 
causing any DNA strand breaks (Hegi et al., 2008). The adduct thymine on O4 
position on DNA may also be removed by MGMT. As stated by Silber et al., (2012) 
during this single step reaction the CH3- group from O
6 -methyl guanine and O4- 
thymine are transferred from the alkylated bases onto cysteine residues which 
results in the restoration of guanine in the DNA and irreversible activation of MGMT. 
This reaction is illustrated for removal of CH3- group in Figure 1.1. 
.  
 
 
 
 
5 
 
Figure 1.1 - Repair of O6-alkylguanine adducts by MGMT. 
 
 
The CH3- group at the O6 position of guanine (O6-Methylguanine) pairs with thymine rather 
than cytosine. MGMT repairs this damage and protects the DNA by transferring the CH3- 
group  to a cysteine residue in the protein (Silber et al., 2012). 
 
This enzyme accepts the CH3- group from the lesion in a stoichiometric reaction of 
1:1 and undergoes ubiquitination and proteasome-mediated degradation. Thus, 
when the active MGMT enzyme accepts the CH3- it gets degraded and not 
regenerated i.e. undergoes suicidal reaction (Rasimas et al., 2004; Kaina et al., 
2010). Also the MGMT catalyses the stoichiometric transfer of a variety of alkyl 
substituents from the O6 position of guanine to an active-site cysteine and prevents 
incorrect base pairing caused by these adducts (Rasimas et al., 2004). 
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Although the alkylating agents are important drugs in cancer chemotherapy, their 
effectiveness is strongly influenced by MGMT DNA repair protein. For example, in 
both methylating and chloroethylating agents, the MGMT can eliminate the initial O6 -
alkylguanine damage in DNA, and thus preventing toxicity to cells (Verbeek et al., 
2008). So, while the removal of adducts by MGMT is beneficial for normal cells, it 
allows development of resistance to DNA damage in cancer cells (Kaina et al., 
2010).  
 
1.1.2 - Base Excision repair (BER) 
Base damage, single strand breaks (SSBs), O6-methylguanine, 8-oxoguanine, uracil, 
thymine glycol, and apurinic/apyrimidinic (AP) sites are common lesions subject to 
repair by BER (David et al., 2007; Dianov and Parsons 2007). The majority of these 
non-bulky lesions are repaired by four proteins found in BER pathway. These 
include, a DNA glycosylase, an AP endonuclease or AP DNA lyase, a DNA 
polymerase, and a DNA ligase (reviewed in Robertson et al., 2009).  These proteins 
are able to remove a single or a small subset of chemically altered damaged base 
and replace it with the correct bases. The BER of DNA damage by glycosylase and 
AP endonuclease is illustrated in Figure 1.2. 
Here the specific damaged bases are recognised by glycosylases, excised and both 
long patch and short patch BER is initiated. This enzyme cleaves then effectively 
removes damaged bases and thus, creates an AP site. The DNA backbone is 
cleaved by DNA AP endonuclease (Robertson et al., 2009). The cleavage by one of 
these enzymes generates a DNA SSB. In short patch BER pathway, the Polymerase 
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β (Pol β) removes the 5'-terminal deoxyribophosphate (dRP) and adds one 
nucleotide into the single nucleotide gap. Then, XRCC1-Lig III complex seals the 
DNA end. Although, the decision to proceed via the long patch or short patch BER 
mechanism is poorly understood (Robertson et al., 2009) Dianov  (2011) proposes 
that if the 5'- sugar phosphate is resistant to cleavage by Pol β, then the long patch 
BER pathway is initiated where, the Pol δ/ε adds 2-8 more nucleotides into the repair 
gap, generating a flap structure that is removed by flap structure-specific 
endonuclease 1 (FEN-1) in a proliferating cell nuclear antigen (PCNA) dependent 
manner. Ligase I then seals the remaining DNA ends. 
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Figure 1.2 - Model for BER pathways. 
 
 
The glycosylase and AP endonuclease first excise the damaged base then incise the arising 
abasic site, respectively generating a DNA SSB with a 5'- sugar phosphate (blue circle). The 
repair is completed via short or long patch pathways. Red blocks indicate the incoming 
nucleotide(s), the size of the blocks represent the number of nucleotides added by the DNA 
polymerases (adapted from Dianov 2011). 
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1.1.3 - Nucleotide excision repair (NER) 
NER is a highly versatile and sophisticated DNA damage removal pathway that 
counteracts the deleterious effects of a multitude of DNA lesions, including the major 
types of damage induced by environmental sources (de Laat et al., 1999). The most 
relevant lesions repaired by NER are the UV induced cyclobutane pyrimidine dimers 
(CPDs) and (6-4) photoproducts (6-4PPs) (Wood 1997; de Laat et al., 1999).  
 
There are two sub-pathways of mammalian NER. 1) Global genome nucleotide 
excision repair (GG-NER) which repairs DNA lesions throughout the genome. 2) 
Transcription-coupled nucleotide excision repair (TC-NER) which is confined to 
repair of DNA lesions in transcribed strands (Fousteri and Mullenders 2008). The 
XPC-RAD23B and UV-DDB complexes recognise and bind to DNA damage-
mediated helix distortion and initiate GG-NER while the TC-NER is triggered by 
blockage of elongating RNA polymerase II complex (RNAPIIo) and interactions of 
CSB and XPG proteins (the XPG having more stable interaction) with the RNA pol. 
Then, the CSF recruits HMGN1, XAB2 and TFIIS to enable cleavage of protruding 
3’mRNA by RNAPIIo for resumption of transcription upon lesion removal (Fousteri 
and Mullenders 2008). Once the lesion has been recognised, all subsequent steps 
leading to assembly of functional NER complex, requires the same NER core factors 
in GG-NER and TC-NER. The UV-DDB and XPC-RAD23 recruit the basal 
transcription factor TFIIH. The TFIIH complex, which has two DNA helicase activities 
(XPB and XPD) unwinds the DNA duplex in the immediate vicinity of the base 
damage, and generates a bubble in DNA. Then the ERRCC1-XPF and XPG DNA 
endonucleases cut the damaged strand at 3’ and 5’ sides of the damage. This 
incision generates an oligonucleotide fragment (~27-30 nucleotides in length) 
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containing the damaged bases. This fragment is excised and the 27-34 nucleotide 
gap is repaired by DNA polymerases δ or ε as well as the PCNA and replication 
factor C (RFC). The damaged DNA is then sealed by DNA ligase I or ligase III. This 
process of DNA damage recognition and removal by NER pathway is summarised in 
Figure 1.3. 
 
Figure 1.3 - Model for NER pathway.
 
XPC-R23 complex recognises the bulky lesion and binds to the undamaged strand of DNA 
(A), TFIIH is recruited to the site (B), the lesion is verified by XPD leading to formation of the 
pre-incision complex through interaction with XPD resulting in the recruitment of XPA, RPA 
and XPG (C), the XPF is recruited to the pre incision complex through interaction with XPA 
leading to DNA incision 5’ (D), which produces a free 3’-OH group available for initiation of 
repair synthesis by the replication machinery, and in turn triggers 3’ incision by XPG (E). 
DNA ligase III or ligase I seals the nick to complete the process (F) (Fagbemi et al., 2011) 
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Deficiency in TC-NER is associated with mutations in the CSA and CSB genes that 
give rise to a rare disease Cockayne syndrome (CS) (Fousteri and Mullenders 2008). 
 
1.1.4 - Mismatch repair (MMR) 
MMR system is employed to detect and repair base-base mismatches and insertion-
deletion loops that escape their exonucleolytic proofreading activity during DNA 
replication (Jiricny 2006). Once the error is detected the mistake is excised, and the 
gaps are filled in with correct sequences.  
 
Mismatch recognition in human cells is predominantly mediated by MutS homologue 
(MSH), heterodimer proteins containing MSH2 and MSH6 subunits. The MSH2 
heterodimerises with MSH6 or MSH3 to form MutSα or MutSβ respectively, both of 
which are ATPases that play a critical role in mismatch recognition and initiation of 
repair (Li 2008). The MSH heterodimer subunits undergo an ATP-dependent 
conformational change, which recruits the MLH heterodimer containing MLH1/PMS2 
subunits. The MSH/MLH complex is translocated towards the strand cut (such as a 
gap between Okazaki fragments) and eventually encounters proliferating cellular 
nuclear antigen (PCNA). PCNA interacts with MSH2 and MLH1 and is thought to 
play roles in the initiation and DNA re-synthesis steps of MMR. It has been proposed 
that PCNA may help localise MutSα and MutSβ to mispairs in newly replicated DNA.  
 
While PCNA is essential for 3’- directed MMR the EXO1 is essential in both 3’-and 5’-
directed MMR. For 5’ directed MMR the excision is straight forward by the 5’ to 3 
exonuclease activity of EXO1. For 3’-directed MMR, the endonuclease function of 
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PMS2 is activated by presence of the 3’ nick, and stimulated by RFC, PCNA and 
ATP to introduce a second nick 5’ to the mismatch. The replication factor C (RFC) 
dependent endonuclease activity plays a critical role in 3′ nick-directed MMR 
involving EXO1 (Li 2008). 
  
MSH2-MSH6 preferentially recognises base-base mismatches and insertion-deletion 
loops of 1-2 nucleotides while MSH2-MSH3 has preferences for larger insertion-
deletion loops. DNA polymerse fills the gap by synthesis of new DNA and DNA ligase 
seals the ligation. A model for MMR is illustrated in Figure 1.4. 
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Figure 1.4 - Human MMR. 
 
The MSH2-MSH6 or MSH2-MSH3 heterodimeric ATPase complex recognises and binds to 
the mismatch and recruits the MLH1-PMS2 complex. The PCNA clamp recruits MMR 
proteins to the replication fork while the clamp loader RFC loads PCNA. RPA binds to single 
stranded DNA during the excision and facilitates the DNA repair synthesis by Polδ. Finally 
Lig 1 ligates remaining nicks after synthesis is performed (Jeppesen et al., 2011).  
 
 
 
Mutations in MMR genes (hMLH1 and hmSH2) may cause hereditary non-polyposis 
colorectal cancer (HNPCC) and familial non-HNPCC which is associated with 
microsatellite Instability (Jiricny and Nystrom-Lahti 2000; Jiricny and Marra 2003; 
Boland and Goel 2010). 
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1.2 - DNA Strand breaks 
DNA DSBs occur when the sugar backbones of both strands are broken close 
enough to disrupt the Watson-Crick base pairing, resulting in the liberation of two 
DNA ends (Bassing and Alt 2004). DSBs can be generated by; exposure to IR, 
certain classes of anticancer chemotherapeutic drugs such as alkylating agents, as a 
consequence of normal cellular oxidative metabolism, the action of recombinase 
activating gene (RAG)-mediated VDJ recombination during the process of 
immunoglobulin production (Ramsden et al., 2010). In addition, the DSBs are formed 
from combination of two independently induced single strand breaks that occur within 
about 10 base pairs of each other (Chadwick 1994). Also the DSB formation is a 
conserved step in the initiation of meiotic recombination (Richardson et al., 2004).  
 
Although, the DSB is considered the most difficult lesion to repair eukaryotic cells 
have evolved specialised and redundant systems to detect and repair chromosomal 
DSBs within the context of normal G1/S, intra-S, and G2/M checkpoints (Bassing and 
Alt 2004). 
 
Some of the well-known agents that cause DSBs and different types of DSB repair 
pathways (with main focus on NHEJ repair pathway) will be described next. 
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1.2.1 - DSBs initiated by Oxidative Damage 
When a high-energy radiation strikes molecules in its path, electrons may be 
displaced from atoms within the molecule. Thus, result in loss of one or more 
electrons and conversion of electrically neutral molecules to one that carry electrical 
charge. This is known as an ionising radiation event. Unlike some chemical agents, 
whose damaging potential are strongly dependent on diffusion processes and thus 
may be affected by sub-cellular structures, the IR is typically highly penetrating and 
the ionisation events are complete within a few microseconds at the site of the 
molecule which it anticipates to damage. The energy deposited in cells depends on 
the level of dose range which the cell is exposed to over a length of its decay tract. 
Thus the measure of energy transfer as an ionising particle to any material is referred 
to as Linear Energy Transfer (LET) which is usually expressed in units of kilo-
electron volts per micrometre (keV/µ) (Leonard et al., 2004).  
 
The radiation may be in the form of an atomic particle such as alpha (α) and beta (β) 
particles or in the form of an energy wave such as X and gamma ( ) rays. The -rays 
penetrate a higher energy radiation compared to other forms of radiation. The 
radiation absorbance dose, i.e. the amount of energy that IR deposits in a unit of 
mass of matter such as human tissue, is expressed in a unit called gray (Gy), where 
1 gray is equal to 1 joule per kilogram or miligray which is one thousandth of a Gy.  
 
The oxidative damage may be induced as a consequence of normal metabolism, 
inflammation and IR. The oxidative damage induced by normal metabolism is not  as 
harmful to the cell as the IR induced damage since the previous occur at relatively 
isolated positions along the DNA molecule, whereas, the IR deposits the energy 
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unevenly and tend to create clusters of radicals around the DNA leading to multiple 
independent lesions within a localised region of DNA.  As reviewed by Ulsh (2010), 
the randomly deposited energy by IR produces clustered DNA damage, also known 
as locally multiple damaged sites (LMDS), which is essentially several regions of 
DNA damage within a short DNA segment. The LMDS was initially introduced by 
Ward (1985). Some of these lesions are the abasic sites (separation of a base from 
the sugar, leaving behind an unpaired base), base alterations (additional bonds 
between atoms or new chemical groups attach to the base) or single (a strand break 
in the phosphodiester backbone) and DSBs in the DNA. Also, two or more DNA 
lesions of the same or different nature may be produced in close proximity to each 
other on opposite DNA strands (also known as bi-stranded lesions), generally within 
one-two helical turns of the DNA molecules (Hada and Georgakilas 2008). 
 
Ionising radiation can also impair or damage DNA when alpha particles, beta 
particles or x-rays create ions which physically break one or both of the sugar 
phosphate backbones or break the base pairs of the DNA.  
 
Since, water is the largest component in the cell the charged molecules converted 
from neutral atom interacts mostly with the water molecule (a process known as 
radiolysis) and generates intermediates called reactive oxygen species (ROS). The 
ROS create free radicals (a highly unstable, reactive molecule that poses an 
unpaired electron) such as, hydrogen peroxide (H2O2), hydroxyl radical (OH
.) and 
superoxide radical (O-2
.), which damages the DNA.  Thus, the removal of electrons 
by species such as the free radicals, a process called oxidation, is one of the main 
causes of mutations in DNA. 
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The superoxide anion, arising either through metabolic processes or following 
oxygen “activation” by physical irradiation, is considered the “primary” ROS, and can 
further interact with other molecules to generate “secondary” ROS, either directly or 
prevalently through enzyme or metal-catalysed processes (Valko et al., 2007). 
 
For example, when cells in vivo are under stress, an excess of superoxide release 
free contaminated iron molecules. The released Fe2+ then participate in the Fenton 
reaction (Fe2+ +H2O2→Fe3+ + •OH+OH−), generating highly reactive hydroxyl free 
radical (OH.) which can easily break the DNA chemical bonds (Valko et al., 2007).  
 
According to Leonard et al., (2004), the H2O2 is not a free radical and does not react 
directly with biomolecules, however, it is biologically significant as it interacts with 
superoxide in the presence of transition metals, such as iron and copper and leads to 
formation of highly reactive and most deleterious ROS and OH. through the Haber-
Weiss reaction.  The superoxide radical also participates in the Haber–Weiss 
reaction (O2•− +H2O2→O2 + •OH+OH−) which combines a Fenton reaction and the 
reduction of Fe3+ by superoxide yielding Fe2+ and oxygen (Fe3++O2•−→Fe2+ +O2) 
(Valko et al., 2007).  
 
Certain viruses such as the human papilloma virus (HPV), Epstein-Barr virus (EBV), 
hepatitis B virus (HBV), human T-lymphotropic virus type 1 (HTLV-1 ) integrate their 
genome in DNA. According to Williams et al., (2011), the integration of the HPV 
genome in DNA can lead to inflammation which may then result in production of ROS 
and progression of cervical cancer. In primary liver carcinoma, which is associated 
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with hepatitis B virus infection, G.C + T.A transversions are the predominant p53 
genome mutation (Cheng et al., 1992). 
 
Also the cells of the immune system produce both the superoxide anion and nitric 
oxide during the oxidative burst triggered during inflammatory processes. Under 
these conditions, nitric oxide and the superoxide anion may react together to produce 
significant amounts of a much more oxidatively active molecule, peroxynitrite anion 
(ONOO−), which is a potent oxidising agent that can cause DNA fragmentation and 
lipid oxidation (reviewed in Valko et al., 2007). 
 
Oxidation can also produce oxidised bases in the DNA for example the guanine 
analogue 8-hydroxyguanine (oh'Gua)' formed in human cellular DNA as a by-product 
of normal metabolic processes is an abundant base modification in mammalian DNA 
whose levels increase with oxidative stress (Cheng et al., 1992).  When Cheng et al., 
(1992), inserted oh’Gua in E.coli cells they have detected misreading of guanine 
which give a mutation frequency of 0.7% and the twenty two of the 23 mutations 
were G + T substitutes.  
Another endogenously occurring damage to DNA is some of the reactive products 
derived from the reactive nitrogen species (RNS), such as the nitrogen dioxide 
radical (NO2) and peroxynitrite (ONOO
-) (Wiseman and Halliwell 1996). The ROS 
and RNS can damage both the nucleus and mitochondrial DNA. The damage 
induced by these compounds may be due to formation of DNA adducts that may 
impair base pairing or block DNA replication and DNA transcription. Also in some 
cases the DNA bases may be lost or DNA SSBs may occur as a result of ROS and 
RNS DNA damage (reviewed in Jackson and Bartek 2009). 
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1.2.2 - DSBs initiation in B and T cell development 
During the early B and T cell development, the variable regions of the 
immunoglobulin (Ig) and the T cell receptor (TCR) which directly binds to the antigen 
is assembled together with a mechanism known as V(D)J recombination process. 
This process begins when the recombination activating genes RAG1 and RAG2 
makes a single strand nicks between the V (variable), D (diverse) and J (joining) 
gene segments and the adjacent recombination signal sequences (RSSs) (Bassing 
et al., 2002). The nick made by RAG protein between the RSS and its adjoining DNA 
generates a 3 hydroxyl (OH) end on the coding segment. The newly formed OH 
group on the coding DNA is copied to the phosphate group in the opposite strand, 
forming a DNA hairpin on the coding end and leaving blunt DSB on the signal end 
through the direct trans-esterification (Brandt and Roth 2004). 
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1.3 - DSB repair mechanisms  
In eukaryotes there are three enzymatically distinct mechanisms that can recognise 
and repair DSB with different fidelity; homologous recombination (HR), non-
homologous end joining (NHEJ) and single strand annealing (SSA). The repair of 
DSBs is likely not straightforward because DNA lesions caused by IR may not 
always be ideal substrates for repair by HR mechanisms that are normally employed 
during replication restart  (Willers et al., 2004). 
 
1.3.1 -  Non-Homologous End Joining (NHEJ) Pathway  
Through the use of genetic and biochemical studies the scientists have identified 
several key proteins in NHEJ pathway. The most extensively studied NHEJ repair 
proteins are the DNA-dependent protein kinase DNA-PK which, includes the 
Ku70/Ku80 heterodimer (Ku) and the DNA dependent protein kinase catalytic subunit 
(DNA-PKcs), Artemis, X-ray cross complementing 4 (XRCC4), XRCC4 like factor 
(XLF) and DNA ligase IV (Wood et al., 2001).  
 
The NHEJ is essentially the canonical DSB repair pathway. This pathway functions 
primarily in the early phases of the cell cycle and directly re-ligates the DNA broken 
ends without requirement of homology between the broken ends (Rothkamm et al., 
2003). As the DSBs leave the two broken ends of the DNA with additional, deleted or 
damaged nucleotides, the prerequisite for the ligation of the two end of the DNA is 
first the removal of these nucleotides. Also, the ligation reaction creates small 
sequence mutations around the break so the re-joining of the two DNA ends that 
may be mutated can result in errors. Thus, the NHEJ is error-prone due to the lack of 
re-joining of the original ends of the DNA (Mladenov and Iliakis 2011).  
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The DSBs created via the V(D)J recombination are also repaired in a single joint by 
the NHEJ DNA repair machinery (Market and Papavasiliou 2003). The DSB repair 
proteins (DNA-PKcs, Ku70, Ku80, XRCC4, Ligase IV, and Artemis) are all involved in 
V(D)J recombination (Mansilla-Soto and Cortes 2003). The Figure 1.5 will first briefly 
outline the role of the key genes found in NHEJ repair pathway. Then each of these 
key genes (with main focus on Artemis gene) will be described in more detail. 
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Figure 1.5 - Main steps involved in NHEJ.  
 
 
 
DSB is recognised by the Ku heterodimer (a), DNA-PKcs is recruited to the break by Ku 
heterodimer and DNPK complex is formed, (b) DNA-PKcs recruits Artemis (c), DNA ends are 
processed by a complex consisting of XLF, XRCC4, DNA ligase IV, and Artemis (d) DNA-
repair factors dissociate and the DSB is repaired (d) (adapted from Misteli and Soutoglou 
2009). 
 
 
Briefly, three main steps are involved in NHEJ repair of DSBs; end binding, 
bridging and end processing and ligation. The DSB recognition and binding step 
requires the binding of Ku heterodimer to DNA ends and recruitment of the DNA-
PKcs to the break site (West et al., 1998) which, bridges the broken DNA ends. Also 
due to the fact that the DNA ends at the break are rarely compatible the DNA-PKcs 
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recruits the Artemis protein which acquires endonucleolytic activity and digests 5’ 
and 3’ DNA overhangs. Following, compatible DNA ends are re-ligated by a protein 
complex containing DNA ligase IV which is stabilised and stimulated by XRCC4 and 
Cernunos-XLF (Burma et al., 2006). 
 
1.3.1.1 -  Ku Heterodimer 
The Ku heterodimer is a DNA-binding protein which comprises of two tightly-
associated subunits of ~70kD and 83 kD (Ku70 and Ku80, respectively; Ku80 is 
sometimes referred to as Ku86) (Smith and Jackson 1999). Although, the two 
subunits of heterodimer have weak primary sequence homology they are very similar 
in structure as each subunit includes three domains: an N-terminal α/β globular 
domain with the Rossmann fold, a centrally located DNA binding β barrel domain, 
which is central to the interactions with DNA, and the extended α-helical arm near 
the C terminus (Jones et al., 2001).  
 
Ku may act solely as a sensor of DNA damage, binding to ends of a DSB and 
signalling events that indirectly affect DSB repair (e.g. cell cycle regulation) through 
induction of DNA-PK activity or it may play a more direct role, including protection of 
ends from degradation, bridging of DNA ends prior to joining, or recruitment of other 
proteins that repair DSBs (Ramsden and Gellert 1998). According to Shin et al., 
(2004), the broken ends of the DNA with either blunt or fidelity ligation are promoted 
by the Ku70/Ku80 heterodimer. Briefly the Figure 1.6 summarises the role of 
Ku70/Ku80 heterodimer in the repair of NHEJ repair of DSB.  
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Figure 1.6 - Binding and bridging of DNA ends through Ku heterodimers. 
 
 
 
 
         
The broken DNA molecule is missing a base and is blocked by a non-ligatable moiety (black 
circle) on the right-hand side (a) Ku heterodimer binds to both ends at the break (b) and 
interacts with each other to form a bridge between the each ends of the DNA (c) (adapted 
from Jones et al., 2001).  
 
If the broken ends are compatible, ligation would be rapid and efficient. However, if 
the ends are not a competent substrate for ligation (e.g. hairpins from V (D) J 
cleavage, non-complementary overhangs, etc.), one or both of the Ku heterodimers 
could translocate internally, continuing to stabilise the intermolecular association of 
the ends (i.e. form a bridge between the two ends) and permit processing to occur 
until a substrate that is competent for ligation is produced (Ramsden and Gellert 
1998).  
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1.3.1.2 -  DNA-Dependent Protein Kinase (DNA-PK) 
The DNA-PK complex, which includes Ku70/80 heterodimer and DNA-PKcs, is a key 
player in NHEJ pathway of DSB repair (reviewed in Burma et al., 2006). The DNA–
PK components are also important in a variety of other processes, including the 
modulation of chromatin structure and telomere maintenance (Smith and Jackson 
1999). The DNA-PKcs is a large catalytic subunit (~460-kDa in size) and is one of 
the members of the phosphatidylinositol-3-kinase-like (PIKK) family of 
serine/threonine protein kinases. Other members include Ataxia Telangiectasia-
Mutated (ATM), Ataxia and Rad3 related (ATR), mammalian target of rapamycin 
(mTOR), suppressor of morphogenesis in genitalia (SMG-1) and 
transformation/transcription domain-associated protein (TRRAP) (Leuther et al., 
1999; Lempiainen and Halazonetis 2009).  
 
A study by Chan et al., (2002)  has shown that phosphorylated DNA-PKcs plays 
important role in the repair of DNA DSBs, by virtue of its localisation at the site of 
damage. Once the DNA DSB is recognised by the Ku heterodimer the DNA-PKcs are 
recruited to the site of the DNA damage. Upon binding to DNA ends, DNA-PKcs 
becomes active and exhibits serine/threonine kinase activity and is phosphorylated 
(Lee and Kim 2002). It then functions as a scaffold and bridges the broken DNA ends 
in a synaptic complex containing two DNA-PKcs molecules (DeFazio et al., 2002). 
DNA-PKcs provides binding sites for other NHEJ proteins such as nuclease Artemis 
(Ma et al., 2002), required for the trimming of the DNA ends or XRCC4/DNA ligase IV 
complex involved in the re-joining step of NHEJ  (O'Driscoll and Jeggo 2002).  
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1.3.1.3 -  Artemis 
The Artemis is one of the most recently identified NHEJ repair protein located on 
chromosome 10p13 and has a predicted molecular weight of 77.6kDa (Moshous et 
al., 2000). This protein belongs to metallo-β-lactamase superfamily and is composed 
of three identifiable regions; the β-Lactamase homologous region (aa 1-155), the 
associated β-CASP domain (aa 156-385), and the COOH-terminal region (aa 386-
692) (Poinsignon et al., 2004). When Poinsignon et al., (2004), investigated the role 
of β- Lactamase and β- CASP domains with regard to V(D)J recombination and DNA 
repair after IR, they have found that the DNA repair during V(D)J recombination and 
after IR are quantitatively different, as different regions of the Artemis are required for 
the DSB repair. The β-CASP region for example, participates within the β-Lactamase 
region in forming the catalytic site of Artemis (Poinsignon et al., 2004). The COOH-
terminal region of the Artemis may be required for DNA repair after IR (Poinsignon et 
al., 2004). The metallo β-lactamase region shows homology to yeast PSO2 and 
murine SN1. The conserved homology of β-lactamase region and the catalytic 
activity of β-CASP are crucial for the functioning of the Artemis protein. The C 
terminal consists of eight Serine-glutamine (SQ)/ threonine-glutamine (TQ) domains 
required for ATM, ATR, and DNA-PKcs proteins carry out phosphorylation of Artemis 
(Poinsignon et al., 2004). 
 
The Artemis protein has shown to have exonuclease and endonuclease activities 
when in the presence of DNA-PKcs and ATP. Mutations in Artemis protein encoded 
DNA Cross Link Repair 1C Gene (DCLRE1C) gene in 29 SCID patients has been 
reported by (Pannicke et al., 2010). In total, 13 different mutated DCLRE1C alleles 
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were detected and the most mutations (59%) were gross deletions of exons 1-3 or 
exons 1-4.   
 
The DNA-PKcs auto-phosphorylation at the T2609–T2647 cluster, in the presence of 
Ku and target DNA, is required for Artemis mediated endonuclease activity. Also the 
DNA-PK autophosphorylation regulates Artemis access to DNA ends (Ma et al., 
2005). The Artemis:DNA-PKcs complex gains DNA endonuclease activity that 
specifically targets and cleaves single-stranded to double-stranded DNA junctions 
(including 50 or 30 overhangs, hairpins, flaps, bubbles, loops and gaps) (Ma et al., 
2005). After the trimming of excess or damaged DNA, the Artemis:DNA-PKcs 
complex may de-bind and permit the ligase complex, XRCC4:DNA ligase IV, which 
completes the joining of the two DNA strands. 
 
The Artemis:DNAPKcs complex also has hairpin-opening activity. Although, Artemis 
alone has 5’ to 3’ single-strand-specific exonuclease activity, upon complex formation 
with and phosphorylation by DNA-PKcs gains endoncleolytic activity which is critical 
for the hairpin-opening step V(D)J recombination and for the 5’ and 3’ overhang 
processing in NHEJ (Ma et al., 2002). As explained earlier, during V(D)J 
recombination, the RAG proteins create DNA hairpins at the V, D, or J coding ends, 
and Artemis is essential to open these hairpins prior to binding.  
 
The DNA-PKcs and Artemis are only detectable in vertebrates (reviewed in Ma et al., 
2002) suggesting the absence of hairpin activity in eukaryotes. Different hairpin 
sequences are opened by the native DNA-PKcs and full-length Artemis in variable 
ways and with varying efficiency. The sequence dependent variation in the efficiency 
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and even the position of hairpin opening by Artemis:DNA-PKcs is important from the 
standpoint of immunologic diversity (Lu et al., 2007). The way which the 
Artemis:DNAPKcs complex processes the two ends of the DNA and gets the DNA 
ready to repair the DSB is demonstrated in more detail in Figure 1.7. 
 
Figure 1.7- DNA-PK and Artemis mediated DNA end processing. 
 
 
Two SSBs resolve into a DSB with long overhangs (1). The Ku70/80 heterodimer binds the 
DNA end to confer protection and recruit DNA-PKcs (2). When bound to a DNA end, DNA-
PK autophosphorylates and undergoes a conformational change that alters the orientation of 
the DNA such that (4) Artemis can now recognise the ssDNA–dsDNA junction of the 
overhang, make an intra-strand incision and cleave the fragment via its exonuclease activity 
(5). With reduced affinity for the now blunt DNA, autophosphorylated DNA-PKcs eventually 
dissociates leaving Ku-bound DNA ends ready for further processing by NHEJ factors 
(adapted from Goodarzi et al., 2006). 
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1.3.1.4 -  XRCC4, XLF and DNA Ligase IV complex 
The XRCC4 promoter consists of an N-terminal head domain which constitutes β-
sandwich and a long helical C-terminal stalk which constitutes α-helixes. The head 
domain and the stalk are held together by van der Waals contacts and form a helix 
turn helix (HTH) structure which faces the major groove and interacts with the DNA 
backbone (Junop et al., 2000). 
  
The XRCC4-like factor (XLF, also known as Cernunnos) has structural similarity to 
XRCC4 and could be required for XRCC4-Ligase IV complex recruitment to DNA 
ends or could help the XRCC4-Ligase IV complex to bridge with other NHEJ 
components such as Ku and DNA-PKcs (Ahnesorg et al., 2006). 
 
The DNA ligase IV is a nuclear enzyme that joins the breaks in the phosphodiester 
backbone of DNA. Although, the DNA ligase IV carries out the ligation step, it 
requires the binding of XRCC4 to do so. The XRCC4 functions as a regulatory 
element to stabilise DNA ligase IV, to stimulate ligase activity, and to direct the ligase 
to the site of DNA breaks via its recognition helix and DNA-binding capacity.  
 
A complex of XRCC4, XLF and DNA Ligase IV performs the final ligation step in 
NHEJ. According to Li et al., (2008), the possible modes of interaction between 
XRCC4, XLF and Ligase IV are formed by; linker region between Ligase IV BRCA1 
COOH-terminal domain (BRCT) binding to XRCC4’s coiled-coil, the folded 
XLF/Cernunnos contact of XRCC4 via the head domains, the C termini of XLF 
molecules unfold and bind to Ligase IV in a similar way to XRCC4, the XLF and 
XRCC4 form a heterodimer and bind to Ligase IV in the composite coiled-coil region. 
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When Chen et al., (2000) have co-expressed human DNA ligase IV and XRCC4 in 
insect cells and purified an active complex of these proteins to near homogeneity 
they have found that the DNA ligase IV-XRCC4 associates with both Ku and the 
catalytic subunit (DNA-PKcs) of DNA-PK at the ends of DNA molecules to allow the 
DNA ligase IV-XRCC4 complex to bind specifically to DNA ends and acts as an 
alignment factor, holding together the short complementary single-strand ends of 
linear duplex DNA molecules.  However, Ku and DNA-PKcs have markedly different 
effects on DNA end joining by DNA ligase IV-XRCC4. Ku inhibits intermolecular DNA 
joining, whereas DNA-PKcs stimulates intermolecular DNA joining even in the 
presence of Ku (Chen et al., 2000).  
 
When Ahnesorg et al., (2006), has reintroduced wild-type XLF into NHEJ-deficient 
2BN cells derived from a radiosensitive and immune-deficient patients lacking XLF 
due to an inactivating frameshift mutation their radiosensitivity and NHEJ defects 
were corrected. Thus, the XLF constitutes a novel core component of the mammalian 
NHEJ apparatus. 
 
Another protein implicated in mammalian NHEJ is the DNA polymerases of the Pol X 
family that are thought to mediate strand-filling steps in the pathway (Ma et al., 
2005). 
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1.3.2 -  Homologous Recombination (HR) Pathway 
The HR repairs double-strand DNA breaks, single-strand DNA gaps and interstrand 
cross links with high fidelity (Krejci et al., 2012). The HR occurs during S and G2 
phases and repairs the DNA DSBs using homologous chromosomal or sister 
chromatid DNA as a template for synthesis of new error-free DNA (Shin et al., 2004). 
During this process a Holliday junction is created whereby lost genetic information 
from the undamaged sister chromatid (mitosis) or homologous chromosome 
(meiosis) is used to restore the original information lost at the site of the break 
(Helleday 2003; Wyman et al., 2004). 
 
This process is conserved from bacteria to man and recent observations suggest that 
mitotic HR is essential for faithful replication in vertebrate cells (Helleday 2003). 
Different HR mechanisms exist in different organisms and at different biological 
circumstances (Jackson 2002).  
 
The initial step in HR is thought to be a 5’ to 3’ exonuclease re-sectioning of the DNA 
end to produce a 3’ ssDNA overhang (Helleday 2003). The ensuing 3’ ssDNA tails 
are then bound by Rad51 in a process that is influenced by a range of other proteins 
including replication protein A (RPA), Rad52p and Rad54p (Jackson 2002).  A 
central player in HR is the strand exchange protein, called Rad51 in eukaryotic cells 
(RecA in E coli). During synapsis (homolog search and DNA invasion are collectively 
called synapses) the Rad51 facilitates the formation of a physical connection 
between the invading DNA substrate and homologous duplex DNA template, leading 
to the generation of heteroduplex DNA (D loop). The D-loop intermediates are where 
the 3’-end of the invading strand primes DNA synthesis off the template duplex DNA 
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(Li and Heyer 2008). The 3’ terminus of the damaged DNA is then extended by a 
DNA polymerase that copies information from the undamaged partner, and the ends 
are ligated by DNA ligase I. Finally, after migration, the DNA crossover, i.e. the 
holiday junctions are resolved by cleavage and ligation to yield two intact DNA 
molecules. A model of HR repair of DSBs which occur in eukaryotes is illustrated in 
Figure 1.8. 
Figure 1.8 - Main steps involved in HR. 
 
 
 
HR initiates with processing of DNA DSB in the 5’3’ direction by the MRE11-Rad50-NBS1 
complex to form 3’ overhangs. RAD52 binds to ssDNA-RPA and recruits RAD51 to form a 
nucleoprotein filament that searches for homologous DNA molecule. RAD51-bound DNA 
exchanges DNA strand with the undamaged, homologous DNA molecule, resulting in 
formation of recombination intermediate heteroduplex DNA (Holiday Junction). Holiday 
junctions are resolved by structure-specific endonucleases and branch migration, restoring 
the original lost genetic information (adapted from Jackson 2002). 
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Following resolution and separation of the two sister chromatids by the action of 
resolvase enzymes, DNA replication is completed and genomic integrity at the site of 
the DSB is maintained (Ip et al., 2008). 
 
According to Saintigny et al., (2002), patients with Werner syndrome (WS), an 
uncommon autosomal recessive disease with features of premature aging and 
genetic instability, is defective in HR pathway. A physiological role for the WRN 
RecQ helicase protein in RAD51-dependent HR and a link between defective 
recombination resolution and limited cell division potential, DNA damage 
hypersensitivity, and genetic instability in human somatic cells was detected in a 
study reported by (Saintigny et al., 2002). Also the BRCA 1 defect in breast cancer 
patients may lead to defective processing of DSBs via HR in these patients. 
 
1.3.3 -  Single-Strand Annealing (SSA) 
SSA is a process that is initiated when a DSB is introduced between two repetitive 
sequences oriented in the same direction. Four steps have been suggested for the 
repair of DSBs by SSA (Figure 4): (i) an end resection step which is needed for the 
formation of long 3'-ssDNA, (ii) annealing step in which the two repetitive sequences 
are annealed together forming a flap structure, (iii) a second resection step in which 
the flap structures (formed by the regions between the repeats) are resected and 
finally, (iv) the DNA ends are ligated. An example of direct SSB repair is illustrated in 
Figure 1.9. 
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Figure 1.9 - SSA model for repair of a two-ended DNA DSB. 
 
 
 
 
 
After DNA DSBs are introduced the DNA ends are resected 5’3’ direction and 3’ 
overhangs containing complementary repeat sequences (dark blue regions) are generated. 
The complementary ends are paired. The non-complementary ends are removed by FEN-1 
like nuclease. DSBs are ligated (adapted from Helleday et al., 2007). 
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This chapter to this point has focused more on different types of DNA damaging 
agents that cause DSBs, the DNA repair mechanisms that recognise and repair 
different DNA damages (with particular emphasis being around the DNA DSBs). 
However, as the overall aim of this research is to detect the cause of radiosensitivity 
in 84BR and 175BR patients, the next step of our discussion will be largely based on 
a discussion for different types of diseases associated with defective DSB repair 
mechanisms (especially those diseases that are associated with defective NHEJ 
repair pathway). 
 
Also, since the patient 84BR under study is considered over responder or over 
reactor to radiotherapy, the effects of radiotherapy on this patient will be discussed in 
more detail. Then, a discussion on a small group of patients found in population that 
are classified as over responders to radiotherapy will put an end to this chapter. 
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1.4 - Radiosensitivity and human syndromes  
 
There are number of human genetic disorders which are characterised by defective 
DSB response to IR. Animal models reveal that defects in any component of NHEJ 
pathway can lead to hypersensitivity to IR, genome instability, immunodeficiency and 
cancer (Bassing and Alt 2004). In humans, defects in the specific genetic 
components of NHEJ also result in predisposition to cancer (lymphoma and 
leukaemia) or to extreme radiosensitivity. For example, defects in ligase IV (Riballo 
et al., 1999) deficiency in Artemis expression (Musio et al., 2005) or a mutation in the 
DNA-PKcs gene are associated with extreme clinical and cellular radiosensitivity and 
increased cancer incidence (Abbaszadeh et al., 2010). Diseases that exhibit 
radiosensitivity are listed in Table 1.3. 
 
 
Table 1.3 - Radiosensitivity associated disorders. 
 
Syndrome Defect References  
Ataxia telangiectasia (A-T) ATM (Chun and Gatti 2004) 
Radiosensitive Severe Combined 
Immunodeficiency (RS-SCID) 
Artemis 
DNA-PKcs 
(Kobayashi et al., 2003; 
van der Burg et al., 2009) 
Ligase IV syndrome LIG4 (Chistiakov et al., 2009) 
Nijmegen Breakage Syndrome (NBS) NBS1 (Bakhshi et al., 2003) 
Breast / ovarian cancer BRCA1 (Gatti 2001) 
Blooms syndrome BLM  Ellis et al., 1995 
DNA-PKcs syndrome DNA-PKcs 
(van der Burg et al., 2009; 
Abbaszadeh et al., 2010)  
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1.4.1 - RS-SCID  
Defects leading to a reduction in functional Artemis endonuclease activity at the 
cellular level manifest extreme radiosensitivity. In human subjects, Artemis deficiency 
results in radiation sensitive severe combined immunodeficiency (RS-SCID). This 
disorder was originally identified in Athabscan speaking Americans who display high 
level of SCID (Murphy et al., 1980), hence the name SCID-A. SCID-A is 
characterised clinically by extreme radiosensitivity and by a complete absence of T 
and B cells due to a failure of the receptor recombination stage of V(D)J 
recombination (Dvorak and Cowan 2010). 
 
Nicolas et al.,1998 showed that a number of radiosensitive T – B – NK + SCID 
patients without mutations in the RAG genes and without any mutations in any of the 
five key NHEJ repair genes (DNA-PKcs, Ku70, Ku80, XRCC4, XLF, Ligase IV). Then 
the Artemis gene was identified by (Moshous et al., 2000) was involved in the 
pathogenesis of RS-SCID. Also a study by Noordzij et al., (2003) confirms that the 
deletions and missense mutations in the Artemis gene can cause RS-SCID with 
defective coding joint formation and lead to an early and complete B-cell 
differentiation block. Artemis deficiency also causes mild telomere dysfunction 
phenotype and show significantly elevated IR induced telomeric fusions (Yasaei and 
Slijepcevic 2010).  
 
The increase radiosensitivity of RS-SCID to gamma rays is not restricted to the cells 
of the immune system, but is also a characteristic of fibroblasts. An example is an. 
This patient with T-B  severe combined immunodeficiency, whose cells have defects 
closely resembling those of NHEJ-defective rodent cells showed dramatic 
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radiosensitivity, decreased DSB re-joining, and reduced fidelity in signal and coding 
joint formation during V(D)J recombination. Also the patient was defective neither in 
the known factors involved in NHEJ in mammals (Ku70, Ku80, DNA-dependent 
protein kinase catalytic subunit, XRCC4, DNA ligase IV, or Artemis) nor in the Mre11-
Rad50-Nbs1 complex. Then a research by a French group with Turkish-Italian-
German collaborators analysed five new patients and identified the XLF protein 
which happen to be mutated in 2BN which was responsible for radiosensitivity as 
reintroduction of wild type XLF rescued radiosensitivity in these patients (Dai et al., 
2003; Ahnesorg et al., 2006). Van der Burg et al., (2009) also reports the first human 
patient with the radiosensitive T-B severe combined immunodeficiency with a DNA-
PKcs missense mutation.  
 
Attempts to correct the deficiency in Artemis gene in cells by transduction with 
lentiviral gene expression vectors containing the Artemis cDNA has led to over-
expression of Artemis in a number of mammalian cell types (Multhaup et al., 2010). 
However, over-expression has also resulted in a loss of cell viability, associated with 
increased DNA damage and elevated apoptosis as a result of abnormal activity of 
the Artemis endonuclease inducing DNA breaks (Multhaup et al., 2010). While such 
findings have significant implications for the role of gene therapy approaches for the 
treatment of SCID, it also reveals a potentially novel mechanism which may explain 
radiosensitivity in human cell types. 
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1.4.2 - Ataxia Telangiectasia (A-T)   
A-T is a human autosomal recessive disorder characterised by progressive 
cerebral degeneration, immunodeficiency, lack of balance (Ataxia), dilated 
blood vessels of the eye (ocular Telangiectasia) and skin, radiosensitivity, 
predisposition to lymphoreticular and other malignancies, and cell cycle 
checkpoint defects (Lavin and Shiloh 1997).  A-T is caused by a mutation in 
ATM gene which is central to cell cycle checkpoint responses such as 
intracellular signalling; DNA-damage induced cell cycle checkpoints and DNA 
DSB repair.  
 
Patients with A-T either lack the ATM protein or ATM kinase activity or have 
mutations in ATM gene. Thus, a defect in a single ATM gene could cause a diverse 
problem such as ataxia, cancer susceptibility, radiosensitivity, characteristic 
translocations and immunodeficiency. Also, ATM-deficient cells show enhanced 
sensitivity and greatly reduced responses to genotoxic agents that generate DNA 
DSBs, such as IR and radiomimetic chemicals (Rotman and Shiloh 1999).  
 
Xu and Baltimore (1996), examined the ability of ATM deficient (ATM -/- ) mice cells 
(which they have created in their laboratory) to arrest cell cycle at G1 following 
gamma irradiation and UV irradiation. According to their results the ATM deficient 
cells exhibited an intermediate defect in cell cycle arrest following higher dosage (>5 
Gy) of radiation. This characteristic support the idea that ATM is responsible for 
signalling the P53 mediated cell-cycle arrest that follows IR. ATM is also required for 
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efficient G1 to S phase transition during the cell cycle progression (Xu and Baltimore 
1996). 
 
A-T cells exhibit defective induction of all checkpoints in response to DSBs. The 
abnormal responses of A-T cells to IR include increased chromosomal breaks and 
radioresistant DNA synthesis, impaired p53-dependent arrest in G1 and other cell 
cycle checkpoint defects (reviewed in Delia et al., 2000). 
 
Other defects in the cellular responses of A-T cells to IR might also contribute to their 
radiosensitivity, such as defective induction of NF-kB (Rotman and Shiloh 1999). 
Inhibition of NF-kB activation was shown to enhance IR-induced cell death of normal 
cells and introduction of a truncated IkB-a corrected the hypersensitivity to IR and 
streptonigrin of A-T cells (reviewed in Rotman and Shiloh 1999). 
 
A study by Sandoval et al., (1999) investigated the mutational spectrum of the ATM 
gene in a cohort of sixty six unrelated A-T patients living in Germany. They have 
identified 46 different ATM mutations among which were the amino acid deletion, 
amino acid substitutions, frameshift deletions, frameshift insertions, nonsense, 
missense and splicing mutations and 26 sequence polymorphisms and variants 
scattered throughout the gene. The majority of the mutations were truncating, 
confirming that the absence of full length ATM protein is the most common molecular 
basis of A-T. Cultured cells from A-T patients are also hypersensitive to IR and show 
defective activation of radiation-induced cell cycle checkpoints; including retarded 
p53 stabilisation (reviewed in Sandoval et al., 1999). The radiation sensitivity of A-T 
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cells generally is assumed to result from an inability to delay the cell cycle to allow 
sufficient time to repair DNA damage (Meyn 1995). 
 
The ATM protein activates several cellular functions such as the p53, cell cycle 
checkpoints and apoptosis in response to DNA damage. The defect in ATM gene in 
A-T patients leads to suppression of these pathways and the A-T phenotypes 
described above.  
 
So to recap, the mutation of the ATM gene regulating cell cycle control and DSB 
repair is associated with clinical and cellular radiosensitivity in A-T. 
 
1.4.3 - Nijmegen Breakage syndrome (NBS) 
 
The NBS is a rare autosomal recessive syndrome of chromosomal instability. Some 
of the characteristic features of the NBS are microcephaly at birth, combined 
immunodeficiency and predisposition to malignancies and cellular hypersensitivity to 
IR (Chrzanowska et al., 2012). 
 
The first reported NBS case was described in 1979 in a Dutch boy with 
microcephaly, stunted growth, mental retardation, café-au-lait spots and 
immunodeficiency. Then in 1981, his brother was reported to have same clinical 
symptoms by researchers at the University of Nijmegen in Netherlands hence the 
name, Nijmegen breakage syndrome which was named by the Dutch group 
(Weemaes et al., 1981).      
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Although, the clinical features of the NBS and AT are different the NBS shares a 
number of cellular features with A-T notably, a specific sensitivity to IR, characteristic 
chromosomal rearrangements in cultured and a predisposition to malignancies, 
particularly lymphoid cancers.  
 
The gene mutated in NBS was cloned in 1998. This gene termed the NBS1 gene 
encodes a protein called Nibrin which is a member of the hRad50/hMre11 protein 
complex involved in DNA DSB processing in HR (Varon et al., 1998). Nibrin together 
with Mre11 and Rad50 is part of a trimeric complex (M/R/N complex) that is 
conserved between yeast and mammals (Demuth and Digweed 2007). 
 
Although, there is controversy in literature the deficient G1- to S-phase and G2 to 
mitosis transitions have been reported for NBS cells (Demuth and Digweed 2007). 
The NBS1 is involved in signal transduction for cell-cycle checkpoints as a substrate 
of ATM kinase and, when this mechanism is defective, induces impaired G2 
checkpoint control and also allows continued DNA synthesis in the presence of 
DSBs, so-called radio- resistant DNA synthesis (RDS) (reviewed in Tauchi et al., 
2002). 
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1.4.4 - Bloom’s Syndrome (BS)  
BS as reviewed in German (1995) and Ellis et al., (1995) is a rare autosomal 
recessive disorder characterised phenotypically by retarded growth, hypersensitivity 
to IR, sun sensitivity, immunodeficiency and predisposition to a wide variety of 
cancers at an early age. The gene mutated in Bloom’s syndrome, BLM, encodes a 
member of the RecQ family of DExH box-containing DNA helicases (Ellis et al., 
1995). Some genes in the DExH family e.g. PB, XPD, and ERCCG genes are found 
in DNA repair and mutations where such genes are found in XP and Cockayne 
syndrome patients.  
  
The BS gene product, BLM, is a 159 kDa DNA helicase enzyme belonging to the 
RecQ family (Turley et al., 2001). It was found that BS cells are much more sensitive 
to the irradiation than control cells at the end of S and at G2 phases. The rate of 
induction of chromosome breaks is significantly increased and that of chromatid 
breaks and exchanges is also increased, though to a lesser degree (Aurias et al., 
1985). 
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1.5 - Over responders to radiotherapy  
Radiotherapy is an important modality of treatment for a wide variety of histologically 
distinct cancers. Most cancer patients receive radiotherapy alone or in combination 
with other forms of therapy. Approximately 20% of patients experience side effects or 
normal tissue toxicity during radiotherapy, which can include mild erythema to 
ulceration and haemorrhage and occasionally neuropathy and paralysis. Also a few 
individuals manifest disproportionately severe normal tissue toxicity (NTT) to IR and 
such patients are often referred to as radiotherapy (RT) “over-reactors”. Such 
individuals respond so extremely to RT that NTT can be life-threatening. The Table 
1.4 summarises normal tissue toxicity for skin. However standardised scales of NTT  
for all tissue and organ types have been developed (Cox et al., 1995). 
 
Table 1.4 - NTT (Skin) following radiotherapy. 
 
RTOG 
Scale 
Normal tissue toxicity 
0 No side effects. 
1 Faint, dull erythema, dry superficial desquamation. 
2 Tender erythema, moist deep desquamation, oedema. 
3 Extensive moist desquamation, increased oedema. 
4 Ulceration, haemorrhage, tissue necrosis. 
5 Death (over-reactors). 
            
 
 
There is considerable inter-patient heterogeneity in the development of NTT as a 
consequence of RT which has been recognised for over half a century (e.g., 
Holthusen 1936). During clinical RT, normal tissue tolerance levels are appreciated 
and severe sequel is avoided in the majority of patients.  
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The NTT scoring system was developed by the Radiotherapy Oncology Group 
(RTOG) (e.g. Cox et al., 1995) and the Late Effects Normal Tissue Task Force 
Subjective, Objective, Management and Analytic (LENT/SOMA) provided 
standardised scales of NTT for all tissue types (Pavy et al., 1995).  
  
In addition many studies have examined the development of NTT in breast cancer 
patients following RT and have demonstrated the occurrence of NTT such as 
telangiectasia, fibrosis, oedema, atrophy, ulceration and neuropathy, at a predictable 
rate. For example, slight fibrosis in approximately 15% of patients; moderate in 5% 
and severe in 5% of patients (e.g. Fehlauer et al., 2003; Hoeller et al., 2003). 
 
A classical example of an over-reactor disease is A-T in which inherited mutations in 
the ATM gene controlling cell cycle control and DNA DSB repair is associated with 
extreme clinical and cellular radiosensitivity (Lavin and Shiloh, 1997). Moreover, 
Abbaszadeh et al., (2010) have recently demonstrated a unique mutation in DSB 
repair gene DNA-PKcs which resulted in clinical and cellular radiosensitivity in a 
patient whom died as a consequence of RT-induced NTT. 
 
As demonstrated in the previous section the core cause of radiosensitivity in these 
individuals is due to some form of defect in the repair of DNA DSBs or signalling 
pathways that are involved in the repair of DNA damage. 
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1.5.1 - 84BR and 175BR Patients: Over-responders to radiotherapy  
Briefly, some of the clinical data known from the literature for the two cell lines under 
study are as follows: 
1. The patient cell line 84BR is an adult female with breast cancer who had 
extreme reaction to radiotherapy. 
2. The patient cell line 175BR is an adult male with multiple primary tumours of 
independent histological origin but no evidence of over-reaction to 
radiotherapy. 
 
A skin biopsy from the patient 84BR who have had adverse reactions at radiotherapy 
was provided to Dr Arlett (MRC Genome Damage and Stability Centre, Sussex 
University) by Professor N.M. Bleehan (MRC Clinical Oncology and 
Radiotherapeutics Unit, Cambridge). The patient from which the 84BR cells were 
derived can be categorised at a RTOG class three patient with severe oedema, 
swelling and persistent fibrosis. Cell strains developed from this patient biopsy had a 
reduced competence for RPLD (repair of potentially lethal damage) which is a form 
of a measure used to detect the level of cell survival to genotoxic agents such as IR.   
 
In a study by Arlett et al.,1989 the RPLD assay was used to measure the effect of 
potentially lethal damage of IR on the survival of five fibroblast cell strains (84BR and 
83BR (both from radiosensitive breast cancer patients) A-T patient CS (patient with 
Cockayne’s syndrome) and 1BR.3 (DNA repair normal individual).  Their results 
revealed that the 84BR was not only sensitive to IR but also lacked in RPLD while 
the rest of the cell strains under study were only slightly sensitive than the normal 
individuals and showed little capacity for RPLD. Another study by Alsbeih (1996) 
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looked at the recovery ratios (RR) of the three hypersensitive cell lines (84BR, 
GM739 and 180BR) to radiation and detected a significantly higher RR for those cell 
lines compared to the controls.  
 
Thus, some of the studies conducted on 84BR cell line confirm the hypersensitivity of 
84BR cell line to IR at cellular level and a defect in the ability of the cells to repair the 
DNA damage. 
 
An established cell line for 175BR patient was also provided by Dr Arlett but originally 
was isolated from a non-affected skin biopsy by Professor Bruce Ponder (Cambridge 
Research Institute, Cambridge, UK). A brief history of this patient can be observed in 
a family pedigree illustrated in Figure 1.10. As can be seen from the pedigree the 
most of the family members of the 175BR patient exhibit a multiple number of 
tumours independently, some of which are the brain tumour, breast cancer, bowel 
and pancreas cancer while the 175BR patient is the only member that exhibits 
multiple tumours. The patient 174BR, the brother of 175BR, also exhibits multiple 
primary tumours. It is also very unfortunate that majority of his family members who 
have had cancer have died.  
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Figure 1.10 - Cancer Prone Kindred. 
 
 
 
 
 
 
 
From the literature we know that the cytotoxic chemotherapy and radiotherapy exerts 
its anticancer effect by inducing DNA damage e.g. DNA strand breaks and DNA 
crosslinks. Also the efficacy of DNA repair mechanisms in cells will be important in 
governing the response to anticancer therapy. Therefore, the aim of this project will 
be briefed in the next page. 
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1.6 - Project Aim 
The aim of this project is twofold; first to determine if the 84BR and 175BR exhibit 
cellular radiosensitivity. Thus, once the radiosensitivity in the two patients are 
identified the next aim of the research will be to determine if the radiosensitivity in 
these patients is associated with failure to effectively repair the DNA DSBs. 
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Chapter 2 - Clonogenic assays  
 
2.1 - Introduction        
In order to determine the cellular radiosensitivity of 84BR and 175BR fibroblast cell 
lines, clonogenic assays were first conducted with IR to establish sensitivity. Then 
clonogenic assays with nitrogen mustard (HN2) were carried out, to determine the 
defective DNA repair pathway (NHEJ or HR) responsible for the potential cellular 
radiosensitivity in 84BR and 175BR patient fibroblast cells.  
 
Clonogenic assays are a reliable method for the determination of inherent cellular 
sensitivity to a variety of DNA damaging agents. Briefly, a cell that is not 
reproductively dead and has retained the capacity to divide after exposure to IR or 
other cytotoxic agents has the potential to form a clone or colony, and it is said to be 
clonogenic (Munshi et al., 2005). The clonogenic cell survival assay, first described in 
1950s for the study of radiation effects on reproductive survival of cells, is still a 
widely used experimental approach to test the effects of radiation, drugs or genes on 
the growth and proliferative characteristics of cells in vitro (Munshi et al., 2005; Guda 
et al., 2007). This assay is also known as colony forming assay (CFA) and it can be 
performed on monolayer cultures as well as cells growing in semi-solid soft agar 
media. The monolayer CFA measures effects of drug or radiation toxicity on 
anchorage-dependent cell growth while soft-agar CFA measures anchorage-
independent growth (Yung 1989).  
 
In this chapter the clonogenic assays were used to identify differences in the 
response to genotoxic agents such as IR and HN2. In clonogenic assays the cell 
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survival is demonstrated with a cell survival curve, which defines the relationship 
between the doses of the agent used to produce an insult and the fraction of cells 
retained to reproduce. From the survival curve the D10 (dose of radiation required to 
reduce colony survival to 10%) is determined, which is used as a quantitative index 
of a given cell types response to the lethal action of the radiation or drug exposure.  
  
There are many published papers where scientists have conducted the clonogenic 
assays on various cell types, a few of which are summarised below; 
 
A previous study by Abbazsedeh et al., (2010), demonstrates the use of clonogenic 
assay for the determination of hypersensitivity of XP14BR patient with Xeroderma 
Pigmentosum (XP) to IR.  In a study by Arlett and Cole 1989 the clonogenic cell 
survival assays are also used to determine the hypersensitivity of A-T patients to IR. 
In this study the D0 (mean lethal radiation dose), for five normal, (1BR.3, 1BR.2, 
48BR, GM730 and 54BR), based on seventy-four survival curves, was at 
1.457±0.018 Gy, while the D0 based on fifteen survival curves for five A-T 
heterozygotes (ATHM4BI, ATHM1SF, ATHF4BI, ATH96TO and ATHM7BI) was at 
1.280±0.037 Gy. Thus, the results show a slightly more radiosensitivity to IR in A-T 
patients compare to their five counterparts. A larger study, by Paterson et al., (1979) 
on 143 strains, consisting of twenty one supposedly normal and hundred twenty two 
cancer patients (such as patients with Hodgkin’s disease, Lymphoma, malignant 
melanoma and breast cancer) was conducted  where a total of 407 survival curves 
were generated. Their study also demonstrates hypersensitivity in those patients to 
IR with clonogenic assays. 
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Although, clonogenic assay is a widely used technique, in some circumstances, the 
clonogenic assays may be misleading particularly when using primary (non-
immortalised) cells. Here cells may be very viable and able to divide very efficiently 
and may not form colonies very well. Under these circumstances it may be useful to 
use some sort of proliferative assay rather than a clonogenic assay. Also primary 
cells are subject to, after a number of population doublings, replicative senescence. 
Here cells are metabolically viable but unable to undergo cell division and thus are 
non-clonogenic. For example, the cell survival assays such as the MTT assay 3-(4,5-
dimethylthylthiazol-2-yl)-2,5-dithenyltetrazolium bromide might be useful. 
 
The MTT, a yellow coloured tetrazolium-based compound (2,5-dithenyltetrazolium 
bromide), is taken up by live cells and reduced to blue-purple formazan crystals by 
mitochondrial enzyme succinate dehydrogenase (Yung 1989) (Yung 1989) and 
(Price and McMillan, 1990). Once the live cells take up this dye the absorbance of 
the MTT solution is read at 540nm to quantify the number of live cells that survive the 
exposure to a cell damaging agent.  
 
In a study by Price and McMillan (1990) the MTT assay was used as an alternative to 
clonogenic assay to measure the response of cultures of primary human tumours 
(HX142 cell line derived from patients with neuroblastoma and MGHU1 and RT112 
from patients with bladder cancer) to IR. Briefly, in this study, the cells were 
irradiated with 60Cobalt source then the MTT was added to the cells. Depending on 
the individual cell requirement the cell culture was incubated for 3-5 hours. The MTT 
solution was then removed and DMSO was added to dissolve the formazan crystals. 
The cell viability was then quantified by measuring the absorbance of the resultant 
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solution. Although, their results showed a reproducible measure of survival with MTT 
compared to clonogenic assays the usefulness of MTT assay in determining the 
radiosensitivity in primary human tumour cultures was limited as it required a several 
optimisation conditions for each cell lines.  
 
Another example is the sulforhodamine B (SRB) assay which was developed by 
Skehan and colleagues in 1990 to measure drug induced cytotoxicity and cell 
proliferation for large-scale drug screening applications (Voigt 2005). Briefly, cells 
grown in a 96 well plate are incubated in sulforhodamine B dye to allow this dye to 
bind to protein basic amino acids. Then the protein-bound to the dye is fixed in 
trichloroacetic acid and dissolved in Tris base solution. The cellular protein is then 
measured by reading the OD values at 510nm. So in principle the more live cells 
there is the more protein is made and the higher is the binding of SRB dye to the 
cells.  This method is more efficient and highly cost effective as large number of 
samples can be tested within a few days, and requires only simple equipment and 
inexpensive reagents (Vichai and Kirtikara 2006). 
 
Although, the clonogenic assay is over 50 years old, it is still the gold standard 
technique for measuring cellular radiosensitivity (Eastham et al., 2001). Hence, the 
use of this technique to detect the radiosensitivity in 84BR and 175BR cancer 
patients was very crucial to my research. Arlett et al., (1989) reports that the clinically 
radiosensitive 84BR patient is also sensitive to gamma radiation at cellular level. 
Thus, the clonogenic assays were performed with gamma radiation to confirm the 
clinical radiosensitivity at cellular level in 84BR and to detect radiosensitivity also at 
cellular level in 175BR patient cell line.  Once the cellular radiosensitivity is detected, 
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the clonogenic assays with HN2 will be conducted to determine the defective 
pathway that may be responsible for the radiosensitivity seen at cellular level.  
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2.2 - Materials and Method 
2.2.1 - Cell Lines 
Human fibroblasts (84BR, 175BR, 1BR.3, NB1) and NB1-tert human dermal 
fibroblast cell lines were used in this study. The 84BR diploid fibroblast cell line was 
derived from a non-affected skin biopsy of radiosensitive breast cancer patient (Arlett 
et al., 1989). The 175BR cell line was derived from a non-affected skin biopsy of an 
individual with multiple tumours of independent histological origin and was a kind gift 
from Professor Bruce Ponder. The NB1 normal diploid fibroblast cell line is described 
in Bridger and Kill (2004) and the 1.BR3 diploid fibroblast cell line was derived from a 
normal individual (Arlett et al., 1988). The NB1-tert cell line was established during 
this research, by transfecting the NB1 cell line with human telomerase reverse 
transcriptase (hTERT) in Brunel institute for cancer genetics and 
pharmacogenomics.  
 
2.2.2 - Cell Culture 
Cells were routinely cultured in complete medium consisting of Dulbecco’s Modified 
Eagle Medium (DMEM). (PAA Laboratories Ltd, Yeovil, Somerset, UK), 
supplemented with 10% (V/V) foetal calf serum (PAA Laboratories Ltd), 2mM L-
glutamine and 100 U mL-1 penicillin and streptomycin (PAA Laboratories Ltd). Cells 
were grown as monolayers in sterile Petri dishes (P100) or tissue culture flasks (75 
cm2) (Nalgen Nunc International, Life Technologies Ltd, Paisley Scotland) at 37 C in 
a humidified atmosphere with 5% CO2 in a class 2 Heraeus 6000 incubator (Heraeus 
Holding GmbH, Hanau, Germany).  
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2.2.3 - Sub-culturing  
Cells were routinely sub-cultured (2x105 cells/ dish) when they reached 
approximately 80% confluence. Medium was aspirated, and cells washed with 10ml 
of versene (phosphate buffered saline and 2mM EDTA), after which 1-2ml of 10% 
(v/v) trypsin (0.25% trypsin with Ethylene-diamine-tetra-acetic-acid (EDTA) was 
added. Immediately after, the cells were transferred to 50ml centrifuge tubes (Nunc), 
recovered by Heraeus Megafuge 1.0 centrifugation (DJB Labcare Ltd, 
Buckinghamshire, England) at 1200rpm and then subjected to a five-fold dilution 
before seeding into fresh 75 cm2 cell culture flasks or P100 Petri dishes. Culture 
media refreshed every 3-4 days and sub-cultured as they became 80% confluent. 
 
2.2.4 - Cell Count 
The 80% confluent cells were trypsinised and re-suspended in 10ml complete growth 
medium in a 15ml centrifuge tube.  Approximately, 10µl of this cell suspension was 
applied to a Neubauer haemocytometer (Weber Scientific International Ltd., 
Teddington, Middlesex, UK) and five 4 x 4 squares were counted using x10 objective 
of an Olympus CK2 inverted microscope (Olympus Europa GmbH, Hamburg, 
Germany). The total cell count established using the formula A= n x r x 104, where A 
is total cell number, n is the mean of cell count, and r is the total re-suspension 
volume.   
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2.2.5 - Irradiation of cells 
Cells were irradiated in suspension in DMEM with 0, 2, 4, 6 and 8Gy gamma 
radiation from a higher activity 60Cobalt source (Puridec Irradiation Technologies, Ltd, 
Oxford) at a distance of 25cm from the source at a dose rate of 1.4-1.5Gy min-1. An 
appropriate number of cells were plated into each of five 10cm dishes containing 
10ml DMEM to allow the growth colonies in each dish. 
 
2.2.6 - Feeder Layers 
Before commencing the clonogenic cell survival assay, cultures of feeder layer were 
established. The feeder layer provides extracellular matrix and certain nutrients for 
the growth of primary fibroblasts. To establish feeder layer, the cells, not greater than 
80% confluence, were recovered by trypsinisation, diluted in approximately 10ml 
complete medium and counted. Cells were diluted to approximately 105 cells per ml 
and subjected to 30Gy gamma irradiation, on a 60Co source, which is a dose rate of 
approximately 2.5Gy per minute. Following irradiation, 2 x 106 cells were cryo-
preserved in liquid nitrogen in 1ml complete medium containing 20% FCS and 10% 
DMSO. One day prior to nitrogen mustard and IR cell survival analysis, appropriate 
feeder cells were recovered from liquid nitrogen and diluted to 104 cells/ml of 
complete medium. Feeder cells (105 per dish) were added to each of twenty five 
10cm plastic Petri dishes and these were incubated overnight.  
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2.2.7 - Clonogenic Cell Survival Assay with Gamma Radiation 
Clonogenic assays following exposure to gamma radiation were conducted as 
described previously (Arlett et al., 2006). In brief, approximately 2.5 x 105 cells were 
seeded in 75cm2 tissue culture flasks and incubated overnight. Cells at 80% 
confluency were trypsinised, suspended in 10ml media and counted to determine the 
number of cells per ml. The cell suspension was serially diluted to concentrations of 
1000, 2000, 3000, 5000 and 8000 cells/ml at a final volume of 5ml. Cells in 
suspension were irradiated with 0, 2, 4, 6 and 8 Gy of gamma radiation. One ml 
aliquots of each cell dilution were transferred into 90mm dishes (5 replicates) 
containing 105 autologous feeder cells in 10ml DMEM. Feeder cells were produced 
by exposure to 30Gy gamma irradiation as described earlier. Cultures were 
incubated for three weeks at 37 C. After three weeks of incubation, colonies that had 
grown were fixed with 70% methanol and stained with 0.5% methylene blue (Sigma 
Aldrich, UK) diluted in distilled water. The colonies were counted and the survival of 
cells was expressed as a percentage of survival of untreated control cells. 
 
2.2.8 - Clonogenic cell survival assay with HN2 
Clonogenic assays following exposure of cells to HN2 was conducted as described 
by (Clingen et al., 2007). In brief, approximately 1 x 105 cells were seeded in five 
75cm2 tissue culture flasks and incubated overnight. Analytical grade HN2 (Sigma 
Aldrich, UK) was dissolved in serum free medium (SFM) immediately before use. 
Overnight cultures, at about 80% confluency, were washed once with versene and 
then treated with 5ml of 2, 4, 6 and 8 μM HN2 for 1 h at 37 C. Treated cells were 
harvested with trypsin, and serially diluted to concentrations of 1000, 2000, 3000, 
5000 and 8000 cells/ml at final volume of 5ml. One ml aliquots of each cell dilution 
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were seeded into 90mm dishes (5 replicates) containing 105 autologous feeder cells.  
Cultures were incubated for three weeks at 37 C. Microscopic examination revealed 
colony formation after three weeks, which were fixed with 70% industrial methylated 
spirit (IMS) and stained with 1% methylene blue. The stained colonies were counted 
and the percentage plating efficiency (PE) was calculated using the following 
equation: PE % = colonies counted / total number of cells plated X 100. 
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2.3 - Results 
2.3.1 - Clonogenic cell survival assays - Radiation  
The response of 84BR and 175BR diploid fibroblast cell lines to increasing dose of 
gamma radiation is shown in Figure 2.1 and is compared with the response from the 
repair normal human diploid fibroblast cell lines, NB1 and 1BR.3. It can be seen that 
for all cell lines the exposure to increasing doses of gamma radiation causes a 
proportionate decrease in clonogenic cell survival. However, in 84BR and 175BR cell 
lines there is an abnormal reduction in colony survival when compared to the NB1 
and 1.BR3 normal fibroblast cell lines. Comparison of the D10 values as illustrated in 
Table 2.1 show that the D10 values for the repair normal fibroblasts is 5 Gy for the 
NB1 cells and 5.7 Gy for the 1BR.3 cells. Therefore, the NB1 cells are 1.47 fold more 
radioresistant than the 84BR and the 175BR cells while the 1BR.3 cells are 1.68 fold 
more radioresistant than the 84BR and 175BR cell lines. These observations confirm 
those of Arlett et al., (1989) and demonstrate the inherent cellular radiosensitivity of 
the 84BR and 175BR fibroblast cell lines. A Student’s unpaired T-test, comparing the 
D10 values of the 84BR and 175BR cell lines with the normal fibroblasts, 
demonstrated that the cells were significantly more sensitive to gamma radiation (P < 
0.05). 
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Figure 2.1- Sensitivity of 84BR and 175BR to IR Compare to Control Cell Lines.
 
Here the clonogenic cell survival of 84BR and 175BR in comparison to the repair normal 
fibroblast 1BR.3 and NB1 following exposure to increasing doses of gamma radiation is 
illustrated. Data are derived from at least five independent experiments and error bars 
represent standard error of the mean survival following exposure to 2, 4, 6, and 8 Gy gamma 
radiation. The P value is < 0.05. 
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Table 2. 1 - The Dose of radiation required to reduce cell survival in a clonogenic 
assay to 10% (D10) in patient and control cells. 
D10 Values 
175BR 84BR NB1 1BR.3 
3.50 3.60 5.13 6.00 
 
To summarise, the exposure of cells to IR has induced DSBs in DNA. Due to the 
defect in the repair pathways the DSBs remained unrepaired. Thereby, the inability of 
the patient cells to repair the DNA damage resulted in more sensitivity to IR than the 
normal cells. Thus, the radiosensitivity seen at cellular level confirms the clinical 
radiosensitivity seen in 84BR.     
 
To determine the defective repair pathway that may be responsible for the cellular 
radiosensitivity seen here, the clonogenic assays were conducted with HN2. 
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2.3.2 - Clonogenic cell survival assays - HN2 
DNA DSB can be repaired by one of two mutually exclusive repair pathways as 
described in Chapter 1. In order to determine if the radiosensitivity of the 84BR and 
175BR cell lines was associated with a defect in either the NHEJ or HR repair 
pathway, clonogenic assays were performed in which the sensitivity to HN2 was 
determined as shown in Figure 2.2. 
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Figure 2.2 - Sensitivity of 84BR and 175BR to HN2 Compare to Control Cell Lines. 
 
Here the cell survival to HN2 exposure is illustrated. The patient cells having survived the 
nitrogen mustard suggests a defect in NHEJ repair and efficient repair via HR pathway. The 
error bars represent the SEM of at least five independent experiments. The P value is 0.18.        
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The Figure 2.2 shows the response of HN2 on 84BR and 175BR together with the 
repair normal NB1 and 1BR.3 cells. It can be observed that for all cell lines as the 
concentration of HN2 increases there is a decrease in clonogenic cell survival. 
However, all cell lines display a similar sensitivity profile in response to HN2 
exposure indicating that the radiosensitivity of 84BR and 175BR cell lines is not due 
to a defect in HR repair pathway and more likely to be a defect in one or more 
components of NHEJ repair pathway. This agent primarily exerts its cytotoxicity by 
the introduction of DNA interstrand crosslinks (ICL) which compromise both strands 
of the DNA. Such adducts are particularly challenging for the cell to repair which 
occurs via a two-step process. Here the ICL is ‘unhooked’ from one strand via the 
action of the nucleotide excision repair-associated endonuclease ERCC1-XPF 
protein complex. This in turn creates a substrate for repair of the strand break by HR.  
Using a Student’s unpaired T-test to compare the half maximal inhibitory 
concentration (IC50)  values of the 84BR and 175BR cell lines with the normal 
fibroblasts it was demonstrated that there were no significant differences in IC50 
values indicating similar responses to HN2 (P = 0.18). This observation indicates that 
the radiosensitivity of the 84BR and 175BR cell lines is not due to a defect in HR 
repair pathway and more likely to be a defect in one or more components of the 
NHEJ repair pathway. 
 
 
 
 
 
 
66 
 
2.4 - Discussion 
The clonogenic cell survival of the radiosensitive patients, 84BR (patient with breast 
cancer) and 175BR (patient with multiple tumours) to IR and HN2 was measured 
against normal human fibroblasts 1BR.3 and NB1. The use of clonogenic cell 
survival assay, being the gold standard technique for measuring cellular 
radiosensitivity for many years (Eastham et al., 2001), had twofold purpose in my 
research: First, the clonogenic assays were conducted with IR to confirm 1) the 
clinical radiosensitivity of the 84BR patient cell line at cellular level, 2) to detect the 
radiosensitivity of 175BR at cellular level. Then, the clonogenic assays were 
conducted with the HN2, to determine the defective pathway that may be responsible 
for the cellular sensitivity to IR seen in these patients. 
 
On the basis of the cell survival curves the 84BR and 175BR patient cells seem to be 
more sensitive to gamma radiation when compared to controls. Thus, the findings 
confirm the observations made by Arlett et al., (1989) and demonstrate the inherent 
cellular radiosensitivity of the 84BR and 175BR fibroblast cell lines. The findings 
further confirm that the 84BR patient is not only clinically sensitive to IR but is also 
sensitive to IR at cellular level.  
 
IR causes DSBs in DNA. The DSBs in eukaryotic cells is repaired via HR or NHEJ 
repair pathways. The NHEJ repair pathway is the principal mechanism of repair of IR 
induced DSBs in eukaryotic cells and can occur in non-dividing cells. In HR repair 
pathway the genetic information lost after DSBs in DNA is borrowed from the sister 
chromatid so the repair of the lost genetic information is achieved in an error free 
manner. 
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To find out which pathway might be defective in the patient cell lines which, lead to 
sensitivity of these cells to IR, clonogenic assays were conducted with HN2. This 
DNA damaging agent exerts it is effect by simply introducing ICRs in DNA. The ICRs 
are repaired via interaction between the NER and HR DNA repair pathway. Here the 
ICL is unhooked by the action of the site specific endonuclease XPF-ERCC1. This 
unhooking then provides a substrate for the action of the HR pathway. Thus cells 
defective in HR are likely highly sensitive to cross linking agents such as HN2 
(Clingen et al., 2007). As illustrated in cell survival curves generated after the 
treatment of cells with HN2 the patient cells are repair normal compare to the 
controls. The normal sensitivity of patient cells to HN2 suggests that the HR DNA 
repair pathway may be functioning normal and it is more likely that the defect is in the 
NHEJ repair pathway. The NHEJ repair pathway repairs the DNA strand breaks in an 
error prone manner in all phases of the cell cycle but with preference to the G1 and 
early S phase. It is well known that defects in any key genes found in NHEJ repair 
pathway results in radiosensitivity (Scott and Pandita 2006). Since, patient cells 
under study display cellular radiosensitivity to gamma radiation the radiosensitivity 
seen in these cells may be due to a defect in the NHEJ repair pathway which leads 
us to further investigate this defect using various other functional and molecular 
techniques. 
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Chapter 3 - DNA DSB Assay ( -H2AX detection) 
 
3.1 -  Introduction  
In Chapter 2 the clonogenic assays conducted with two patient cell lines revealed a 
cellular hypersensitivity of about two fold when compared to repair normal diploid 
fibroblasts. These observations also confirmed that the clinical radiosensitivity of 
84BR patient was evident at cellular level. In addition the cellular hypersensitivity of 
the 175BR cell line may be associated with the increased cancer incidence observed 
in the patient. Moreover, the clonogenic assay conducted with HN2 demonstrated a 
normal HR DSB repair. Thus, the cellular radiosensitivity observed in 84BR and 
175BR fibroblast cells was likely associated with abnormal NHEJ. 
 
To determine if the cellular radiosensitivity observed in two patient cell lines was 
associated with a defect in DNA DSB repair, a phosphorylated H2AX ( -H2AX) assay 
was performed following the exposure of cells to 2Gy of gamma radiation from a 
60Cobalt source.  
 
DNA DSBs occur when both strands are broken close enough to disrupt the Watson-
Crick base pairing, resulting in the liberation of two DNA ends (Bassing and Alt 
2004). They arise from exogenous agents such as, IR and certain chemotherapeutic 
drugs, or endogenously generated from ROS and from chromosomal stress (Scott 
and Pandita 2006). The DSB is probably the most deleterious of the many types of 
DNA damage that exist within the cell and are potentially lethal if not repaired (Scott 
and Pandita 2006). 
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Histones are among the most evolutionary conserved proteins in eukaryotes. They 
can be classified into five groups, namely the four core histones H2A, H2B, H3, and 
H4 and the linker histone H1. There are two copies of the four core histones, so in 
total the eight histones come together to form a histone octamer, which binds and 
wraps about 1.7 turns of DNA, which is about 146 base pairs of DNA. In addition to 
this the H1 protein wraps another 20 base pairs, resulting in two full turns around the 
octamer (Annunziato 2008). This method of packaging allows close to two meters, 
negatively charged molecules of DNA to exist in relatively small 3D space (Bilsland 
and Downs 2005). Despite this enormous degree of compaction, the DNA must still 
be rapidly accessible to permit its interaction with protein machineries that regulate 
the functions of replication, repair and recombination (Ridgway et al., 2002). 
 
Figure 3.1 - Chromatin structure and histone-modifying enzymes. 
 
 
Base pairs of DNA wrapped around a histone octamer consisting of two copies of each of the 
core histones H2A, H2B, H3, and H4. Linker histone H1 is positioned on top of the 
nucleosome core particles stabilising higher order chromatin structure (adapted from 
Fullgrabe et al., 2010).  
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There are a number of histone H2A variants, two of which are the H2AX and H2AZ 
proteins that are highly conserved as unique H2A species from S.cerevisiae to 
humans (Redon et al., 2002). The H2AX represents between 2-25% of the total 
cellular H2A, whereas the H2AZ appears to account for 10% (Redon et al., 2002). 
The H2A variants contain a sequence (SQ) motif conserved at its carboxy terminus 
which is somehow evolutionary from Drosophila to S.cerevisiae (Bilsland and Downs 
2005). It is the phosphorylation of this SQ motif in H2AX immediately after the DSBs 
in the DNA, which is measured to determine the level of DSBs in cells. As one of the 
early studies by (Rogakou et al., 1999) provides evidence that the cells of the normal 
human fibroblast IMR90 and the human breast cancer line MCF7 both respond to 
DNA DSBs caused by IR with the formation of discrete foci containing gamma H2AX. 
Rogakou et al., (1998) also demonstrated that, after DNA DSBs the H2AX is 
phosphorylated on the residue serine 139 in the unique carboxy-terminal tail.  
 
Therefore, within minutes after DNA DSBs, the H2AX is phosphorylated and the DNA 
repair proteins are accumulated in large nuclear domains known as foci at the sites 
of DNA DSBs (Bilsland and Downs 2005). These foci, also known as the DNA repair 
centres, contain hundreds to several thousand phosphorylated H2AX molecules per 
DNA DSB (Rakiman et al., 2008; Bilsland and Downs 2005).         
 
The -H2AX phosphorylation is carried out by the PIKK family of protein kinases such 
as; ATM, ATR (ATM- and Rad3-related or the yeast homologous Mec1 and Tel1) 
and DNA-PKcs. The formation of -H2AX redundantly requires the Met1 and Tel1 
kinases in fission yeast strains (Nakamura et al., 2004). Although, previous studies 
have suggested that the ATM is required for the induction of foci at DSBs, and ATR 
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is involved in the recognition of stalled replication forks when Friesner et al., (2005) 
investigated the ATM and ATR dependency of the formation of -H2AX in M-phase 
Arabidopsis plant cells exposed to IR they have also found that at least a 10% of the 
IR induced -H2AX foci require functional ATR.  
 
One possible role of the -H2AX foci formation at the sites of DNA DSBs could be to 
serve in recruiting proteins that are involved in re-joining DNA ends such as MRE11 
or RAD50 to those sites, either directly, through binding to the -H2AX COOH 
terminus, or indirectly, through an altered regional chromatin structure (Rogakou et 
al., 1999). Paull et al., (2000), investigated the co-localisation of -H2AX and repair 
factors at sites of laser induced DSBs in MCF7 human breast tumour cell lines and 
found that the repair factors Rad50 and Rad51 and the tumour suppressor gene 
(BRCA1) co-localises with phosphorylated H2AX foci at the site of DSBs immediately 
after the DNA damage. The BRCA1 recruitment to the sites of -H2AX 
phosphorylation happens several hours before the Rad50 and Rad51 co-localises.  
 
3.1.1 -  Techniques employed for the measurement of DNA DSBs  
Over the years many techniques have been employed to determine the level of DNA 
DSBs induced by DNA damaging agents such as IR. Few of which will be outlined 
here.  
 The -H2AX assay is used to measure the phosphorylated H2AX as an indicative 
measure for DNA DSBs. The idea in this assay is that, after the exposure of cells 
with IR, the DSBs are introduced and, where there is DSBs there is accumulation 
of -H2AX at it is site as demonstrated by some of the studies mentioned above. 
Then the cells are immunofluorescently labelled with antibodies specific to the 
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phosphorylated H2AX, which binds to the phosphorylated H2AX and fluoresces 
as discrete spots of foci under the fluorescent microscopy. Also from the literature 
it is known that the number of foci approximate the number of expected DNA 
DSBs in the ratio of one -H2AX to one DSB in DNA.  So by scoring the number 
of foci as (<5 foci = DSB repair normal and >5foci = DSB repair defective) the 
DSB repair defect can be established. As the cells are able to repair the DSBs, 
the number of phosphorylated H2AX will drop, in another term are de-
phosphorylated, and in the repair defective cells the level of H2AX 
phosphorylation will persist.  
 
The phosphorylated H2AX used as a marker for the measurement of DNA DSBs, 
can be visualised through the use of imagestream imaging flow cytometry. This 
procedure was recently employed by our group (Bourton et al., 2012), to detect 
the differences in the induction and repair of DNA DSBs in XP14BRneo17 cell 
line from XP patient defective in DNA-PKcs, AT5BIVA cell line from A-T patient 
defective in ATM gene, and MRC5-SV1 SV40 immortalised lung fibroblasts 
derived from repair normal cells. Here cells were exposed to 2Gy of IR to induce 
DSBs then cells were immunofluorescently labelled with antibodies specific for 
phosphorylated H2AX. Through the analysis of frequency and distribution of -
H2AX foci in a minimum of 20,000 cells, our group was able to show a DNA 
DSBs defect in both the XP and AT patients.  
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Figure 3.2 - Imagestream analysis of Gamma-H2AX foci in human cells. 
 
 
 
                      
Multispectral imaging in cells at 30 minutes after exposure to 2Gy gamma radiation is 
illustrated here. Chanel 1: Brightfield image; Chanel 3: Brightfield image with Draq 5 nuclear 
merge; Chanel 5: Nuclear staining by Draq 5. 
 
 The comet assay also known as the single-cell gel electrophoresis (SCGE) is a 
simple, rapid, cheap, versatile and sensitive method for detecting a wide variety 
of  DNA damage including single and double strand breaks (Collins 2004), DNA 
interstrand crosslinks, and base damages that appear as endonuclease sensitive 
sites in individual cells (Olive and Durand 2005). A unique property of the comet 
assay is its ability to detect cellular heterogeneity (nuclei containing mixture of 
damaged and undamaged strand breaks) which is crucial when predicting tumour 
response to specific treatment (Olive et al., 1998; Olive and Banath 2006). 
Different types of comet assays exist where each type vary on the bases of pH of 
the buffer used in lysis buffer at the lysis step. So if the lysis buffer is alkali 
(pH>13) the alkali sites (ALS) are detected as SSB and if neutral (non-denaturing 
at pH <13) then DSBs are mainly detected. However, briefly in this assay, the 
cells are exposed to DNA damaging agents such as IR, then approximately 2µl 
sample is suspended in 0.5% low melting agarose and sandwiched between a 
layer of 0.6% normal melting agarose and top layer of 0.5% low melting agarose 
on fully frosted slides. After the solidification of 0.6% agarose layer, the slides are 
lysed for approximately an hour in pre-chilled lysing solution or longer up to 24 
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hours depending on the types of DNA damage being analysed. Then the slides 
are placed in electrophoresis buffer for 20 minutes at RT, to allow for DNA 
unwinding and then electrophoresed at 20V 300mA. The electric current pulls the 
charged DNA from the nucleus so that relaxed and broken DNA fragments also 
known as comets migrate further from the nucleus than intact DNA. The comets 
formed during electrophoresis are then neutralised using the neutralisation buffer, 
and stained with ethidium bromide to be imaged under the fluoresce microscopy. 
According to Mozaffarieh et al., (2008), the cells containing damaged DNA have 
the appearance of comet with bright head and tail. In contrast, undamaged DNA 
appears as an intact nucleus with no tail Figure 3.3. 
 
Figure 3.3 - Fluorescence microscopy visualisation of comet assay. 
 
 
 
The comet created by electrophoresis has an astronomical body, with head consisting of 
intact DNA and a tail containing damaged and broken pieces of DNA. Intact nucleus with no 
tail represents undamaged DNA (adapted from Hastak et al., 2008). 
 
 
Pulsed field gel electrophoresis (PFGE) analysis the DNA DSBs caused by IR, 
through the separation of broken DNA from extremely large chromosome 
(Gunderson and Chu 1991). Briefly, in this assay the irradiated cells are embedded 
in agarose plugs and lysed to release DNA without any mechanical damage to it 
before subjecting to an electrophoretic condition. During electrophoresis DNA above 
30-50 kb migrates with the same mobility as single large diffused bands. The DNA is 
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then forced to change direction during electrophoresis to allow different sized 
fragments within this diffuse band begin to separate from each other. With each 
reorientation of the electric field relative to the gel, smaller sized DNA will begin 
moving in the new direction than the larger DNA. Thus the larger DNA lags behind, 
providing a separation from the smaller DNA. 
 
Figure 3.4 - A model for PFGE. 
 
 
Whole cells are embedded in agarose and DNA is enzymatically purified and restricted by 
rare cutting enzymes in situ. The agarose plug is then inserted into a well in an agarose gel 
and the restricted fragments are separated by an electric current which pulses from different 
angles (O'Sullivan 2000).  
 
 
The use of H2AX, comet or PFGF assays for the detection of DSB defects in 
radiosensitive patients with various human diseases is known for many years. One 
example is the use of H2AX assay by Abbaszadeh et al., (2010), which revealed an 
altered cellular response to IR as a DSB repair defect in XP14BR cell lines in a 14 
year old XP patient. Other human diseases with evidence for altered cellular 
response to DNA damage where one of these techniques have been employed to 
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detect DSB defect are the Bloom’s syndrome (Nocentini 1995) and Nijmegen 
Breakage Syndrome (Girard et al., 2000). 
  
Kühne et al., (2004), employed immunoflurosence detection of -H2AX nuclear foci 
and pulsed gel electrophoresis assay in AT1BR cell lines, deficient in ATM, from a 
patient with A-T, to analyse the time course for DSB repair between days 1 and 14 
after 2Gy of X-ray exposure. According to their findings the AT1BR cells exhibited a 
substantial fraction of unrepaired DSBs many days after irradiation and contribute to 
radiosensitivity in ATM deficient cells.  
 
Girard et al., (2000), used untransformed skin fibroblasts 87RD102 derived from NBS 
patients displaying radiosensitivity and cell cycle checkpoint defect and 347BR 
derived from a patient with a diagnosis of common variable immunodeficiency.  The 
aim of their research was to find out if the radiosensitivity of the NBS cells was the 
result of a repair defect in these cells or if it can be attributed to impaired checkpoint 
arrest. Using the PAGE assay, they have found a modest but reproducible defect in 
DNA DSB re-joining in 347BR and 87RD102 cells after exposure to IR. 
 
The ability of radiosensitive patient cells (84BR and 175BR) to repair the DSBs 
induced by IR was measured in this study using the -H2AX assay as described in 
materials and method section.  
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3.2 -  Materials & Method 
The detection of phosphorylated H2AX as an indicative measure for the repair of 
DNA DSBs after the exposure of cells to gamma radiation as described by 
Abbaszadeh et al., (2010), will be outlined here in detail.  
 
3.2.1 -  Irradiation of cells 
Cells were grown as monolayers on 13 mm diameter circular coverslips (Sigma) and 
exposed to 2Gy of gamma radiation from a 60Cobalt source.  
 
3.2.2 -  Fixing of cells 
Cells were washed for three times in 5ml PBS and fixed in a 50:50 acetone and 
methanol mixture for 8 minutes at 4ºC, at specific time points (30 minutes, 3, 5 and 
24 hours). Control cells were not exposed to -radiation. After fixing, cells were 
washed twice with ice-cold PBS. 
 
3.2.3 -  Permeabilisation and Blocking 
On each coverslip 0.5 ml Permeabilising buffer (0.5% TritonX100) (Sigma)  in PBS 
was added for 5 minutes, after which the buffer was aspirated then blocking buffer 
(0.2% skimmed milk, 0.1% Triton X-100 in PBS) was applied. Then the cells were 
incubated in a humidified box at 4ºC overnight. The next day, the blocking buffer was 
removed from the cells with three washes of PBS. 
 
3.2.4 -  Immunostaning with Anti-γH2AX Antibody 
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Cells were incubated with 25µl (per coverslip) of anti -H2AX phosphoserine139 
(Clone JW301) mouse monoclonal antibody (Millipore Ltd., Watford, UK) diluted 
1/10,000 in blocking buffer, for an hour at room temperature. After incubation the 
cells were washed with PBS three times with 15 minutes incubation at each wash. 
Cells were then incubated with 200µl/well of secondary antibody Alexa Fluro® 488 
goat anti-mouse IgG (Invitrogen Ltd., Paisley, Scotland, UK)  diluted 1:1000 in 
blocking buffer, for 1 hour at room temperature in dark. Antibodies were then washed 
off with PBS and cell nuclei were counterstained with 2µg/ml of Propidium iodide in 
PBS for 3 minutes and de-stained with distilled water for 20 minutes. 
 
3.2.5 -  Mounting Slides 
Cells were washed, and mounted in mowoil mountant containing 1µg/ml 4’6-
diamidino-2 phenylindole (DAPI) (Sigma Aldrich Ltd). The excess mounting medium 
and air bubbles were removed before sealing the edges of the coverslip with clear 
nail polish. Slides were stored at -20ºC until the analysis.  
 
3.2.6 -   Cell Scoring and Imaging 
Analysis was performed by counting the number of foci in a minimum of 200 nuclei of 
each cell line at each time point (un-irradiated and 30 minutes,3, 5 and 24 hours post 
exposure) using a Zeiss Axioscope fluorescence microscope with a 100X 
magnification objective. Untreated cells typically exhibited 0-2 foci per/cell. Also 
images of each cell lines were captured by using the fluorescence microscopy 
equipped with Photonic Science Cooled charge-coupled device (CCD) camera (West 
Germany) with integration times of between 0.5-10 seconds depending on the 
brightness of staining. 
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3.3 -  Results 
3.3.1 -   -H2AX foci assay: DNA DSB repair  
Exposure of radiosensitive cell lines to 2Gy of gamma radiation induced DSBs in two 
radiosensitive patient cell lines (84BR and 175BR) and in two repair normal 
individuals (NB1 and 1BR.3), which resulted in accumulation of phosphorylated 
H2AX proteins at the sites of DSBs.  Following the cell exposure to gamma radiation 
the cells were fixed, permeabilised and stained with primary and secondary 
antibodies. Then the induction and repair of DNA DSBs in radiosensitive cell lines 
and in normal individuals was determined by counting the number of -H2AX foci in 
the nuclei of untreated cells and those exposed to 2Gy gamma radiation at 30 
minutes, 3, 5 and 24 hours post irradiation.   
 
The induction and repair of DNA DSB in all cell lines was determined by counting the 
number of -H2AX foci in the nuclei of untreated cells and those exposed to 2 Gy 
gamma radiation at 30 minutes, 3, 5 and 24 hours post-irradiation. The data 
displayed in Figure 3 show that in the untreated cells there are more residual -H2AX 
foci in the radiosensitive 84BR and 175BR cell lines (5.12 and 4.32 foci per nucleus 
respectively), compared to the repair normal NB1 and 1BR.3 cells (0.81 and 1.02 foci 
per nucleus). At 30 minutes post-irradiation there is a dramatic induction of foci in all 
cells consistent with the induction of DNA DSB. In the NB1 and 1BR.3 cells the 
number of foci return to near normal levels at 5 and 24 hrs. In the 84BR and 175BR 
cells however, there is a significant (Student’s unpaired T-test) retention of foci at 5 
and 24 hours when compared to the NB1 and 1BR.3 cells.  
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Figure 3.5 - DSB repair measured by formation and disappearance of -H2AX foci in 
radiosensitive cells and controls. 
 
The induction and repair of DNA DSBs in the radiosensitive 84BR and 175BR fibroblasts in 
comparison to the repair normal 1BR.3 and NB1 fibroblast cells. Cells were exposed to 2Gy 
gamma radiation and the induction and repair of DNA DSB was measured by the 
appearance and removal of -H2AX foci in the nuclei of un-irradiated and irradiated cells. 
Data are derived from three independent experiments, the error bars represent standard 
error of the mean and the P value is < 0.05. 
 
 
Since the -H2AX level after five and twenty four hours post irradiation remained 
significantly higher in 84BR and 175BR patient cells a reduced repair in DNA DSBs 
in these cells is clearly visible. However, in the repair normal NB1 and 1BR.3 cells 
the -H2AX returned to near normal levels after five and twenty four hours post 
irradiation thus, indicating an efficient level of repair of DNA DSBs.   
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As illustrated in Table 3. 1 the efficient repair of γ-radiation-induced by DSBs is 
determined by de-phosphorylation of foci (clearing of -H2AX foci) in 84BR and 
175BR patient cells and NB1 with IBR.3 cell lines from normal individuals in five 
independently conducted experiments. 
 
Table 3. 1 - The -H2AX foci formation following 2Gy of gamma irradiation in 
irradiated patient and control cells. 
Number of -H2AX per nuclei 
Time Points (hr) 175BR 84BR NB1 1BR.3 
Untreated 4.2 5.12 0.81 1.02 
0.5 37 39 33 30 
3 22 24 24 20 
5 17 15 5 4 
24 17 15 0.81 0.81 
 
 
So, to conclude, the visualisation of -H2AX formation confirms the clonogenic 
radiosensitivity seen in patient cells and is likely to be associated with a defect in 
DSB repair. 
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3.4 -  Discussion  
The clonogenic assay conducted with IR revealed cellular radiosensitivity in 84BR 
and 175BR patient cells. The IR causes DSBs in DNA which can be repaired via 
NHEJ or HR repair pathways. Then, the clonogenic assays were conducted with 
HN2 to detect the defective DNA DSB repair pathway that may be responsible for the 
cellular radiosensitivity seen in patient cells. This alkylating agent induces cross links 
in DNA, which is repaired primarily by HR repair pathway. The ability of patient cells 
to repair the cross links induced by HN2 suggested a normal HR but a possible 
defect in the NHEJ repair pathway. Then a gamma H2AX assay was conducted to 
find out if the cellular radiosensitivity in both patients is due to a defect in the ability of 
cells to repair the DSBs induced by IR.  
 
The -H2AX assay is a widely accepted technique for the detection and estimation of 
DSBs induced by DNA damaging agents such as IR. The -H2AX assay being the 
most simple and sensitive assay was chosen in our research for the detection of 
DSB repair defect in radiosensitive patient cells.  
 
The H2AX, one of the variants of H2A histone proteins, along with other core histone 
proteins (H2B, H3, and H4) and linker histone (H1) protein compacts two meter long 
DNA in a 3D space. The H2AX constitutes a carboxyl tail which is a highly conserved 
sequence comprising of an SQ motif. Immediately after DSBs are induced this 139 
residue is phosphorylated ( -H2AX) and DNA repair proteins are recruited to the DSB 
sites where a group of H2AX at each site of DSBs are known as foci.  
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Immunofluorescence assay was conducted, where specific antibodies were raised 
against -H2AX, to detect the -H2AX foci formation in the patient cells. At least 200 
foci, each foci containing hundreds to thousands of -H2AX, were viewed and 
images were taken with the florescence microscopy. The number of -H2AX foci 
were counted and plotted against various time points, post exposure to IR. The rate 
of disappearance of -H2AX has been shown to be associated with a greater ability 
to survive following treatment with clinically relevant doses of (2Gy) of IR (Olive and 
Banath 2006; Abbaszadeh et al., 2010).  
 
The -H2AX induction was approximately the same in both the patient cells and the 
repair normal cells after 30 minutes exposure to IR (15 and 14 foci per nucleus). 
Then after 24 hour post irradiation, the level of -H2AX foci was reduced to 5 and 4 
foci per nucleus in 84BR and 175BR cell lines. Thus, indicating a normal DSB repair 
in the controls and DSB repair defect in patient cells. The evidence provided from 
this data strongly dictates a defective NHEJ repair pathway in patient cells.  
 
Here we have demonstrated that the enhanced radiosensitivity in these cell lines was 
associated with a failure to effectively repair DNA DSB following radiation exposure 
as measured in a -H2AX foci retention assay.   
 
Since -H2AX foci loss monitors all repair events, that is, NHEJ and HR (Beucher et 
al., 2009) we sought alternative techniques, which would more specifically measure 
the key genes in NHEJ repair pathway.  So, to determine the defective component of 
the NHEJ pathway an investigation of expression levels of key NHEJ genes was 
conducted using the technique of quantitative real time PCR (qRT-PCR). 
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Chapter 4 - Quantification of NHEJ genes in 
radiosensitive cells by qRT-PCR 
 
4.1 -  Introduction 
The existence of a potential NHEJ repair defect in cells derived from two 
radiosensitive patients (84BR and 175BR) was shown after observing: 
1. Cellular radiosensitivity in a clonogenic assay. 
2. A normal response to the crosslinking agent (nitrogen mustard), as an 
indicative measure to normal functioning of HR pathway. 
3. Abnormal repair of DNA DSB measured by -H2AX retention. 
Taken together, these data suggest the DSB repair defect found in cells is most likely 
due to aberrant or abnormal NHEJ repair causing the cellular and clinical 
radiosensitivity described.  
 
Subsequently, to reveal the possible defect in NHEJ repair pathway the expression 
of the key NHEJ genes was examined using the qRT-PCR. The principal genes 
whose proteins function in this pathway and their locations on different chromosomes 
are shown in Table 4. 1 
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Table 4. 1 - NHEJ repair genes and their locations on different chromosomes. 
Chromosome 
location 
NHEJ repair 
genes 
Protein function in NHEJ 
2q35 Ku80 
Binds to DNA ends and recruits DNA-
PKcs to the break site. 
22q13.12 Ku70 
Binds to DNA ends and recruits DNA-
PKcs to the break site. 
8q11 DNA-PKcs Recruits Artemis. 
10p13 Artemis 
Endonuclease trimming of un-
compatible DNA ends. 
5q13 XRCC4 Promotes gap filling and reseals DSBs. 
13q33 Ligase IV Re-ligates compatible DNA ends. 
2q35 
XLF /Cernunnos 
gene 
Involved in the ligation step. 
 
 
As briefly covered in the Chapter 1, defects in any components of NHEJ pathway can 
lead to hypersensitivity to IR, genome instability, immunodeficiency and cancer 
(Bassing and Alt 2004). In humans, defects in the specific genetic components of 
NHEJ also result in predisposition to cancer (lymphoma and leukaemia) or to 
extreme radiosensitivity. For example, defects in ligase IV (Riballo et al., 1999) 
deficiency in artemis expression (Musio et al., 2005) or a mutation in DNA-PKcs  
gene (van der Burg et al., 2009; Abbaszadeh et al., 2010) are associated with 
extreme clinical and cellular radiosensitivity and increased cancer incidence. 
 
Vis-à-vis published evidence we have employed the qRT-PCR method to 
determine if abnormal gene expression of any key genes found in the NHEJ repair 
pathway is responsible for the cellular hypersensitivity seen in 175BR and 84BR cell 
lines.  
The quantitative or real time PCR is not a new discovery but more of a new 
development by Higuchi et al., (1992), from the traditional PCR assay first discovered 
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by Kary B. Mullis in 1983. To this date the real time PCR has been the gold standard 
for gene expression analysis but, other techniques may also be used to examine 
genetic defects in cells which may lead to abnormal DNA repair processes (D'Haene 
et al., 2010). These include conventional karyotyping, fluorescent in situ hybridisation 
(FISH) analysis, microarray-based copy number screening, multiplex ligation-
dependent probe amplification (MLPA). However, real time PCR distinguishes itself 
from other methods in terms of accuracy, sensitivity, and fast results. Because of 
this, the technology has established itself as the golden standard for medium 
throughput gene expression analysis (Derveaux et al., 2010). Some of the basic 
steps involved in real time PCR method for the detection of gene expression are 
summarised in Figure 4.1. 
 
Figure 4.1 - Steps in nucleic acid quantification by real time PCR. 
 
 
 
Here the processing of a sample using real time PCR as a detection method is illustrated 
(adapted from Stahlberg et al., 2005). 
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The real time PCR detects the amplicon as the reaction is happening and the data is 
gathered at the exponential phase of the PCR reaction. The data is then manifested 
on a amplification plot or a melting curve.  
 
The amplification plot is a graphical representation of gene expression. As the 
fluorescent signal reporter increases to a detectable level the gene expression is 
captured and displayed on this plot. A threshold on this plot is the point at which a 
reaction reaches a fluorescent intensity above background. A cycle threshold (Ct) is 
the cycle at which the sample reaches the threshold. Several mathematical methods 
make use of the Ct value to calculate the gene expression level. One recently 
developed mathematical model is the delta-delta comparative Ct method of relative 
quantification, written in short as 2 -[ΔCt Sample - ΔCt Control] or 2-ΔΔCt (Pfaffl 2001). The 2-
ΔΔCt was employed in this research to detect the expression of NHEJ repair genes in 
84BR and 175BR patient cells. 
 
The dissociation or melting curve provides a graphical representation of the PCR 
products. A single peak on this graph usually suggests a single size product and a 
presence of a peak in the negative control sample usually indicates a primer dimer.  
 
Although, the literature search reveals no specific study on the use of qRT-PCR for 
the detection of NHEJ repair genes in radiosensitive cells the two papers that 
prompted the use of qRT-PCR assay to detect the possible defect in NHEJ repair 
genes were; 
1. The study by Mohrin et al., (2010), which makes use of the qRT-PCR assay for 
NHEJ repair gene expression analysis in quiescent hematopoietic stem cells 
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(HSPCs) from adult mouse cells.  Their findings reveal that the HSPCs are 
intrinsically more resistant to IR exposure than common myeloid progenitors 
(CMPs) and granulocyte/macrophage progenitors (GMPs). They imply that the 
long-lived HSPCs are resistant to IR-mediated cell killing, have enhanced  NHEJ 
repair gene expression and a strong induction of p53-mediated DNA damage 
response (DDR) leading to growth arrest and DNA repair; whereas short-lived 
MPs are molecularly poised to undergo apoptosis and are predominantly 
eliminated in response to genotoxic stress.  
 
2. The study by Chiou et al., (2007) uses qRT-PCR to examine the mRNA 
transcripts of KU70, Ku80, DNA-PK, Artemis, XRCC4, Ligase IV and XLF in 
paediatric acute lymphoblastic leukaemia (ALL) patients. This study reveals that 
the mRNA expressions of all NHEJ members in untreated fresh ALL were 
elevated when compared with (the non-leukemic) thalassemia cases.  The 
overexpressed NHEJ mRNAs were down regulated after therapy i.e. after 
complete remission and mRNA transcripts of Ku80, DNA-PK, Artemis, XRCC4 
and ligase IV were elevated again in relapsed specimens.  Therefore, differential 
mRNA expressions of NHEJ genes were observed between persons of various 
disease statuses.  
 
Based on the studies outlined here a qRT-PCR assay was designed to detect the 
expression of the NHEJ repair genes in two radiosensitive patient cell lines 
compared to the expression of these genes in repair competent normal fibroblasts.  
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4.2 -  Materials & Method 
4.2.1 -  RNA Extraction 
The first critical step prior to commencing qRT-PCR is continual production of high 
quality intact cellular RNA which requires, the yield of the RNA extract, the RNA 
integrity, purity, storage and stability to be of high standard. The steps involved in 
RNA extraction are as follows. 
 
4.2.1.1 -  Cell Lysis 
Medium from cell cultures of 80% confluence was aspirated. The cells were 
thoroughly washed by adding 10ml of ice cold PBS to the cells and gently agitating 
the cells by swirling the Petri dish. The PBS was aspirated; 2ml (as manufacturer’s 
recommendation of 2ml for 10cm dishes) of TRIzol (Sigma Aldrich, Dorset, UK) was 
added to the adhered cells and incubated for 2-3 minutes at room temperature to 
detach the cells from the dish. Further cell detachment and homogenisation was 
achieved by pipetting the cells up and down for several times. The homogenised 
cells were incubated at room temperature for 5 minutes to completely dissociate the 
nucleoprotein complex. Then the cells were collected in 1 ml eppendorf tubes and 
pelleted at 13,000 rpm centrifugation for 1 minute. 
 
4.2.1.2 -  Phase Separation 
Two hundred μl of chloroform was added to the cell pellet in TRIzol, then the tube 
was vigorously shaken for 15 seconds and the cells incubated at room temperature 
for 3 minutes. All work with chloroform performed in fume cupboard (Premier 
Labserve Limited, County, UK) as the chloroform is a narcotic reagent. The samples 
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were centrifuged at 13,000 rpm at 4 C for 30 minutes to separate the sample into 
following phases:  
Top colourless aqueous phase = RNA  
Inter phase     = DNA 
Bottom red organic phase  =  Protein, Lipids 
 
4.2.1.3 -  RNA Precipitation 
The upper (clear) aqueous layer transferred to a fresh 1ml eppendorf tube (Sarstedt 
Ltd, Leicester, UK) with a p1000 (1000 ml) Gilson Pipette (Sarstedt) ensuring that the 
upper layer was not contaminated with the lower two layers. Then 0.5ml of propan-2-
ol was added to the decanted aqueous layer, shaken thoroughly for 15 seconds and 
incubated at room temperature for 10 minutes. Samples centrifuged at 4 C (Sorvall® 
Legend T, Thermo Scientific) for 20 minutes to precipitate the RNA also to form a 
gel-like pellet.  
 
4.2.1.4 -  RNA Wash and Re-suspension 
Following centrifugation the supernatant was discarded and 1ml of 75% ethanol was 
added to the RNA pellet and briefly vortexed for 10 seconds to wash the pellet.  The 
sample was centrifuged at 4 C, 8,000 rpm, for 5 minutes. The supernatant was 
removed and the pellet was air dried for 5 minutes at room temperature. The RNA 
pellet was re-dissolved in 30μl of 1% Diethylpyrocarbonate (DEPC) treated water and 
incubated at 60 C for 10 minutes to dissolve the pellet in solution.  
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4.2.2 -  RNA Concentration and Purity Detection 
Once the RNA was extracted 1μl of RNA was placed in a Nanodrop 2000C (Thermo 
Scientific, Wilmington, USA) and the RNA concentration and purity was determined. 
Pure preparation of RNA had A260 – A280 ratio values in the range of 1.5 to 2. The 
RNA purity was further determined on 1% agarose gel by approximately running 10μl 
1:1 dilution of RNA (200ng RNA suspension in  9µl of DEPC treated water containing 
1µl 6X Loading Buffer (30% w/v/ sucrose, 0.35% orange G) on a 1% agarose gel. 
The RNA purity was then visualised with Ethidium bromide (EtBr) under UV 
transilluminator (Alpha Innotech Corporation, USA). As the RNA degrades fast at RT, 
immediately, after RNA quantification, the RNA in solution was stored at -80 C.  
 
4.2.3 -  Deoxyribonuclease I, amplification grade treatment of RNA 
The quality of the extracted RNA may be influenced by certain factors for example, 
the DNA or protein during RNA extraction may be carried over into the RNA extract 
which, may then interfere with the gene amplification. To circumvent this problem, a 
20µl reaction mix was prepared in a 1ml RNase free microcentrifuge tube (Sarstedt 
Ltd), containing 4µg total RNA, 2µl 10X DNAse I (Deoxyribonuclease I) reaction 
buffer (Sigma Aldrich) 0.5µl (40U/µl) RNase out (Sigma Aldrich) 2µl (1U/µl) DNAse 1, 
Amp Grade (Sigma Aldrich) and DEPC treated water.  The reaction was incubated at 
RT for 1 hour. After the incubation 25mM (2μl) DNase 1 stop solution (EDTA) at pH 8 
was added to the reaction and heated for 15 minutes at 65 C. The RNA sample is 
now ready for reverse transcription. The sample can be stored at -80 C for future 
use. 
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4.2.4 -  cDNA Preparation 
4.2.4.1 -  Annealing of Primers to RNA 
In a 1ml nuclease free-microcentrifuge tube (5 µl) 1µg DNase treated total RNA, 1 µl 
(10mM) dNTP mix (Invitrogen, Paisley, Scotland, UK), 1 µl (250ng) Random primers 
(Invitrogen) were added and the reaction volume was made to 13ml with 6ml DEPC 
treated water. The mixture was heated at 65 C in a heating block (Techne, Fisher 
Scientific, UK) for 5 minutes then incubated on ice for at least 1 minute. Then the 
content of the tube was collected by brief centrifugation. 
 
4.2.4.2 -  Synthesis of First Strand cDNA 
To the content above plus 4 µl (5X) first-strand buffer, 1 µl (0.1 M) DTT, 1 µl (40 
units) RNaseOUT TM RNase Inhibitor, 0.5 µl (100 units) SuperScriptTM  III (all 
purchased from Invitrogen Ltd) and 0.5 µl DEPC treated water were added to make 
up a total volume of 20µl reaction. With gentle pipetting the reaction was mixed up 
and down and incubated at following temperatures (25 C for 5 minutes, 50 C for 50 
minutes and 70 C for 15 minutes) inside the gradient PCR (Peltier Thermal Cycler) 
for 70 minutes. The first DNA strand (cDNA) was stored at -20 C.  
 
4.2.4.3 -  Determining the quality of cDNA 
In an eppendorf tube 10µl ReddyMix (Thermo Scientific), 2µl (5µM) forward GAPDH 
primer (Sigma Aldrich), 2µl (5µM) reverse GAPDH primer and 4µl DEPC treated 
water was added. The reaction was run at following parameters in gradient PCR. 
 
 
 
93 
 
Table 4. 2 - PCR amplification cycles for detection of cDNA quality. 
Number of cycles Temperature ( C) Time 
1 94 5 min 
35 
94 45 sec 
58 45 sec 
72 45 sec 
1 72 10 min 
 
The quality of the cDNA was visualised with EtBr under UV transilluminator and an 
image of the cDNA run was captured. 
 
4.2.5 -  Determining the quality of primers  
Before commencing qPCR it was crucial to know if the primers work well, whether 
there is any primer dimers and if the NHEJ repair genes are being expressed.  A 
PCR reaction made with following reagents answered some of these questions. 
 100ng cDNA from NB1 cell line 
 1µl forward primer (10µM) 
 1µl reverse primer (10µM) 
 16µl 1.5 X ReddyMix 
The volume was made to 20µl with DEPC treated water then the PCR mix was 
amplified at following cycles in the gradient cycler as summarised in Table 4.3.  
 
Table 4. 3 - PCR amplification cycles for detection of primer quality. 
Number of cycles Temperature ( C) Time 
1 95 5 min 
34 
95 40 sec 
60 40 sec 
72 40 sec 
1 72 15 min 
1 4 ∞ 
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4.2.6 -  Determining the quality of PCR products  
The amplified PCR products were run on 1% agarose gel. The 1% agarose gel was 
prepared by dissolving 1g agarose (Fisher BioReagents, New Jersey, USA) in 90ml 
distilled water and 10ml 10 X TBE (89 mM Tris-HCI pH 7.8, 89 mM borate, 2 mM 
EDTA) in the microwave until the agarose was translucent in solution. When the 
solution was hand temperature hot 2µg/ml EtBr was added to the agarose and 
poured in electrophoresis chamber with a comb already in place. Once the gel had 
solidified 1X TBE buffer was poured on the gel, the comb was removed and the PCR 
samples were loaded to the wells. Five µl molecular weight DNA ladder was loaded 
in another well to accurately size the PCR product. The samples were run at 40V for 
50 minutes, and visualised under UV transilluminator. An image of the DNA run was 
captured with the image acquisition end analysis system. 
 
4.2.7 -  Designing Primers for NHEJ repair genes 
The Applied Biosystems (AB) ABI Prism prime express version 2.0 was used to 
design primers for the key NHEJ repair genes. First the primer annealing 
temperature (PARAMS) was set to 60 C, the GC content of the primer was set to 
max: 45 or min: 55%, the primer length was set to min 18bp or max: 22bp and the 
amplicon product size was set to max: 100bp or min: 150bp. Then the icon ‘optimal 
primers’ was selected to retrieve a list of optimal i.e. the best known primers for the 
genes under study. From this list the primer that was the most GC rich at the 3’ end 
of the primer sequence was selected. The FASTA sequence of mRNA of interest 
was downloaded from National Centre for Biotechnology Information (NCBI) and 
loaded into the primer express software. The chosen primer pair sequences were 
then BLASTED in NCBI website to check for specificity of each primer. A list of 
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primers designed and ordered from Sigma-Aldrich for the qPCR analysis of NHEJ 
repair genes are listed in Table 4. 4. 
 
Table 4. 4 - Primer sequences used for the amplification of NHEJ genes during qRT-
PCR analysis. 
 
Gene Primer sequence (5’ – 3’) 
Amplicon size 
(bp) 
Ku70 
F: CCCCAAAGACAAACCAAGTGG 
R: AGCGATGGCAGCTCTCTTAGA 
121 
Ku80 
F: AATGACAGTGCCAAAGCCAGC 
R: CAAGGATATGTCAAAGCCCCC 
113 
Artemis 
F: ACAGGAGACTTCAGATTGGCG 
R: CACTCCTCCCGACTTGGAATT 
145 
XRCC4 
F: TTTGGATAATCTCCTTCGCCC 
R: TTCGCACCCGTAGAATCAGTG 
103 
Ligase 4 
F: CTGCACCTTGCGTTTTCCA 
R: TACCAGATGCCTTCCCCCTAA 
115 
XLF-
cernunnos 
F: TTTGGATAATCTCCTTCGCCC 
R: TCACTTCGCACCCGTAGAATC 
107 
DNA-PKcs 
F: CCAGCTCTCACGCTCTGATATG 
R: CAAACGCATGCCCAAAGTC 
125 
 
 
The dry oligonucleotides were re-suspended to a 100µM concentration with DEPC 
treated water following the manufacturer’s guideline and stored at -20 C. The 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (F: GAAGGTGAAGGTCGGA 
GT and R: GAAGATGGTGATGGGATTTC) was used as an internal control in 
experimental sample to normalise the quantitation of a cDNA target for the 
differences in the amount of cDNA added to each reaction. The normalisation of 
target gene expression levels must be performed to compensate intra and inter-
kinetic qRT-PCR variations i.e. the sample-to-sample and run-to-run variations (Pfaffl 
and Hageleit 2001).  
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4.2.8 -  Optimising Primer Concentration 
In three separate PCR tubes a PCR reaction was prepared at 10µM primer 
concentration and the reaction was run under fast real time ABI PRISIM® 7900HT 
Sequence Detection System (SDS).  
 
 
Table 4. 5 - PCR reaction conducted at 10µM primer concentration. 
 
100ng 
*cDNA 
(µl) 
10µM 
^forward primer 
(µl) 
10 µM 
^reverse primer 
(µl) 
2X 
SYBR Green 
(µl) 
DEPC 
treated 
water 
(µl) 
2 1 1 10 6 
2 1 1 10 6 
2 1 1 10 6 
*cDNA derived from NB1 cell line; ^primer is the GAPDH 
 
A melting curve was generated where each peak in the curve represented an 
approximate expression value of the NHEJ repair genes. Also primer dimer 
formation, if any, was visualised from this graph. 
 
 
4.2.9 -  qRT-PCR 
A master mix consisting of 10μM (1μl) forward primer, 10μM (1μl) reverse primer, 
(except for GAPDH which was used at 5μM) 10μl (2X) SYBR green (Applied Bio-
systems) and 7μl DEPC treated water was prepared in a 0.5ml eppendorf tube. In a 
pre-cooled 96 well plate (Applied Bio-systems) 100ng (1μl) cDNA was pipetted per 
well. To each well 19μl of master mix was added. The plate was then sealed with 
optical adhesive cover (Applied Bio-systems), inverted few times and centrifuged at 
4 C at 12,000 rpm for few seconds. It was important to keep the 96 well plate on ice 
whilst preparing the qRT-PCR reaction to minimise the degradation of cDNA. The 96 
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well plate was placed in ABI prism 7900HT SDS and the reaction was ran under fast 
real time PCR program.  
 
4.2.10 -  qRT-PCR data analysis on SDS.3 Software 
The SDS 2.3 software installed on the ABI PRISIM® 7900HT instrument was used to 
quantitatively run the PCR products. The following parameters; relative quantification 
(∆∆Ct) and container 96 well plate were selected to create an SDS file with a 96-well 
plate map. The detectors (DNA-PKcs, GAPDH, XLF, Ligase IV, Artemis, KU70, 
KU80, XRCC4) once added to the detector tab were assigned to the 96 well plate. 
The endogenous gene and the target genes were selected. The wells not in use 
were omitted. Under the instrument tab the thermal profile was edited to the following 
temperatures and a dissociation stage was added at stage 4. The Table 4.6 
summarises the thermal profile set for the qRT-PCR reaction. 
 
Table 4.6 - The thermal profile set for the qRT-PCR reaction. 
Stage Number of cycles Temperature (ºC) Time 
1 1 50 2 min 
2 1 94 10 min 
3 35 
94 15 sec 
58 1 min 
4 1 72 1 min 
 
The volume of the reaction was kept to 20µl. The real time tab was selected. The 96 
well plate was loaded to the ABI machine and the PCR reaction began under the fast 
run option. After the run was complete, which took approximately 45 minutes, the 
dissociation program was set up. 
 
98 
 
4.2.11 -  Setting up the Dissociation Program 
Under a new document file the absolute quantification assay was selected. The 
template was kept blank and the barcode was left empty. The appropriate detectors 
were added, then under the instrument tab the thermal profile was set to the 
following parameters as in Table 4.7. 
 
Table 4.7 - The thermal profile set for the dissociation curve. 
Stage 
Number of 
cycles Temperature ( C) 
Time (sec) 
1 1 95 15 
2 1 
60 15 
95 15 
 
Data collected at the end of the run was analysed using the SDS.3 RQ manager 
software. The results were plotted on separate bar charts to show the level of gene 
expression in both patient cells. 
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4.3 -  Results 
It can be hypothesised from the clonogenic assays and the γ-H2AX DNA DSB assay 
conducted so far that a defect in NHEJ was responsible and causing the 175BR and 
84BR cell lines radiosensitive. To confirm this hypothesis the expression of the key 
genes (Ku70, Ku80, XLF, XRCC4, DNA-PKcs, Ligase IV and Artemis) found in NHEJ 
in patient cells were measured using the SYBR Green I based qRT-PCR assay.   
 
In order to accurately detect the expression of the key genes found in NHEJ repair 
pathway the quality of the RNA and cDNA had to be carefully evaluated. Also the 
concentration of the primers designed for the detection of NHEJ repair genes had to 
be optimised. 
 
Firstly, the quality of the RNA extracted with TRIzole reagent was measured by 
running the RNA samples from all four cell lines (NB1, 1BR.3, 175BR and 84BR) on 
a 1% agarose gel and an image of all RNA samples was captured on a UV 
transilluminator. From this image one can tell whether the RNA is degraded or intact 
or whether there is any DNA contamination.  
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Figure 4.2 - Total RNA for NB1, 1BR.3, 84BR and 175BR samples. 
 
 
 
 
 
 
Here the image shows the two species of RNA (28S and 18S rRNA) which suggests that the 
extracted RNA is completely intact. The absence of the DNA contamination is an indication 
that a clean RNA preparation was made. Also the 1+Kb DNA ladder and the water control 
illustrated here provided a good measure for smooth running of the RNA on the agarose gel. 
 
Secondly, the quality of the cDNA prepared for all four cell lines under study was 
determined. The quality of the cDNA preparations were measured with the use of 
GAPDH since this gene is widely expressed in all cell types it provides not only a 
good internal control for the running of the sample but also provides a good 
indication to whether a good quality cDNA was being made. The cDNA samples ran 
on 2% agarose gel and the image captured on the UV transilluminator is shown in 
Figure 4.3. 
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Figure 4.3 - cDNA samples for GAPDH in patient and control cells. 
 
 
 
 
 
 
An image of all cDNA samples for GAPDH from four cell lines under study is shown here. 
The cDNA samples are approximately 100bp’s long, which is an indication to a correct length 
of cDNA required for the detection of the expression of NHEJ repair genes. Also the quality 
of the cDNA is of good quality as there is no degradation and no contamination in any of the 
cDNA preps made for the four cell lines. 
 
Thirdly, the primers designed for the NHEJ repair genes were optimised in order to 
achieve an optimum concentration of primer for the running of the qRT-PCR 
products. When a gradient PCR was conducted at 10µM primer concentration and a 
gel image was captured on the UV transilluminator the expression of all NHEJ repair 
genes was clearly observed. 
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Figure 4.4 - Primers at 10µM concentration. 
 
 
 
A normal expression of GAPDH, XLF Ligase IV, XRCC4, Ku70, Ku80, DNA-PKcs and 
Artemis for all four cell lines at10µM concentration is illustrated here.  
 
 
The image in Figure 4.4 confirms not only that the GAPDH, XLF Ligase IV, XRCC4, 
Ku70, Ku80, DNA-PKcs and Artemis are being expressed in all four cell lines but 
also the concentration of primers at 10µM is optimum for the running of the samples 
as there are no dimer formed at this concentration. Thus the 10µM concentration is 
optimum for the running of all four samples for the expression of the key genes found 
in NHEJ repair pathway.   
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Although, no primer dimer was detected when the gradient PCR was conducted with 
all primers at 10µM concentration when a qRT-PCR was conducted with all primers 
again at 10µM concentration a primer dimer was observed with GAPDH. 
 
Figure 4.5 - Melting curve showing the primer dimer with GAPDH at 10µM 
concentration. 
 
 
Images on the left and right panel show dimer formation in GAPDH non template control 
(NTC). 
 
Also when a quantitative PCR reaction was separately prepared and run on a 1% 
agarose gel, as illustrated in Figure 4.6 the presence of primer formation with 
GAPDH at 10µM concentration was once again obvious. Thus, further supporting the 
presence of primer formed with GAPDH in the melting curve.  
 
Figure 4.6 - Primers run at 10µM concentration on 1% agarose gel. 
104 
 
 
 
 
 
 
The primer dimer as circled is illustrated in both images A and B. Image A is a 
replicate of image B.  
 
 
Therefore, to avoid the dimer formation the GAPDH was used at 5µM concentration 
whereas the rest of the primers were used at 10µM concentration. The amplification 
curve shows the effect of the primer concentration on the efficiency of amplification. 
 
 
 
 
 
Figure 4.7 - GAPDH run at 5µM and remaining primers run at 10µM concentration.  
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The amplification curve from real-time PCR shows the effect of the primer concentration. 
 
 
Once the required parameters were optimised, the qRT-PCR assay was conducted 
with SYBR Green I dye to measure the expression of the NHEJ repair genes. The 
repair normal NB1 and 1BR.3 fibroblasts were used as internal calibrators for the 
expression of the NHEJ genes and the levels of gene expression in these cells were 
represented at 1.0. Also the expressions of the NHEJ genes in the radiosensitive 
cells (84BR and 175BR) were plotted relative to the repair normal fibroblasts. 
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Figure 4.8 - NHEJ Gene expression in 84BR radiosensitive fibroblasts. 
 
 
 
Here the expression of the NHEJ genes in the radiosensitive 84BR fibroblasts in comparison 
to the repair normal NB1 and 1BR.3. The data are derived from three independent 
experiments and error bars show standard error of the mean. Gene expression in 84BR cells 
is expressed in comparison to the normal fibroblasts cells (calibrators) in which levels of 
expression are regarded as a level 1. The P value is 0.003.  
 
 
As it is clear in Figure 4.8 there is an approximately 2 fold over-expression of the 
Artemis gene in 84BR fibroblast cells when compared to the repair normal NB1 and 
1BR.3 fibroblasts. Comparison of the expression levels of Artemis in 84BR cells with 
the repair normal fibroblast using a Student’s unpaired T test also reveals a 
statistically significant difference in expression levels. 
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Similarly for the radiosensitive 175BR fibroblasts, it can be seen that there is an 
approximate 1.7 fold over-expression of the artemis protein when compared to the 
control cells. Also a Student’s unpaired T test reveals a statistically significant 
difference in expression levels between the 175BR radiosensitive cells and the repair 
normal control cells. 
 
 
Figure 4.9 - NHEJ Gene expression in 175BR radiosensitive fibroblasts. 
 
 
 
This figure shows the data for the 175BR radiosensitive cell line and is presented in an 
identical manner to that of Figure 4.8. Also the P value for 175BR cell line is 0.007. 
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While the expression of the Artemis is considerably higher in both cell lines a 
marginal decrease in DNA-PKcs, Ku70, Ku80 and XRCC4 and a marginal increase 
in Ligase-IV and XLF were observed in 84BR or decrease in DNA-PKcs, Ku70, 
Ku80, Ligase-IV XLF and XRCC4 were observed in 175BR cells.  Although, the 
dramatic increase in the Artemis expression is more striking than the marginal 
fluctuation observed in the expression of  the remaining NHEJ repair genes is also 
worth mentioning as any change in gene expression could be the consequence of 
some form of defect or abnormality of that gene or of its regulation of gene 
expression. 
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4.4 -  Discussion 
In previous Chapters we have hypothesised from the clonogenic and the H2AX 
assays that the cellular radiosensitivity seen in clinically radiosensitive patient 84BR 
and the patient 175BR may be due to a defect in the NHEJ repair pathway as HR 
pathway was found to be functioning normally.  
 
Then, in this chapter we tried to unveil the defect in NHEJ repair pathway which may 
be responsible for the radiosensitivity observed at clinical and cellular level in 
radiosensitive patients. Hence, to determine this defect, if any in the NHEJ repair 
genes, a qRT-PCR assay was conducted, which enabled us to study the level of 
gene expression of some of the key genes found in NHEJ repair pathway.   
 
The key genes under investigation were the Ku70, Ku80, DNAPKcs, XRCC4, XLF, 
Ligase IV and Artemis. Since the previous studies have clearly shown that any 
defects in any component of NHEJ pathway can lead to hypersensitivity to IR, 
genome instability, immunodeficiency and cancer (Bassing and Alt 2004) the next 
prudent decision in our research was to detect the level of NHEJ repair genes as to 
disclose the reason for the radiosensitivity seen in 84BR and 175BR cells.  
 
Based on the study by Mohrin et al., (2010), and Chiou et al., (2007) also the fact 
that the real time PCR is the golden standard for gene expression was the preferred 
choice for the analysis of the key NHEJ genes in two radiosensitive patient cell lines. 
As discussed in previous chapters certain diseases are known to be associated with 
defective genes in NHEJ repair pathway. Defects leading to a reduction in functional 
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Artemis endonuclease activity are particularly noteworthy. At the cellular level this 
manifests extreme radiosensitivity. In human subjects, Artemis deficiency results in 
RS-SCID. RS-SCID is characterised clinically by extreme radiosensitivity and by a 
complete absence of T and B cells due to a failure of the receptor recombination 
stage of V(D)J recombination (Dvorak and Cowan 2010). Attempts to correct the 
deficiency in cells by transduction with lentiviral gene expression vectors containing 
the Artemis cDNA has led to over-expression of Artemis in a number of mammalian 
cell types (Multhaup et al., 2010). While such findings have significant implications 
for the role of gene therapy approaches for the treatment of SCID, it also reveals a 
potentially novel mechanism which may explain radiosensitivity in human cell types.  
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Chapter 5 - Artemis over-expression and Apoptosis 
in Radiosensitive cells  
 
5.1 - Introduction 
As described in Chapter 1 the key proteins involved in NHEJ repair pathway are; 
Ku70, Ku80, DNA-PKcs, Artemis, XLF, XRCC4 and Ligase IV. The Ku70 is 
associated with Ku80 to form a Ku heterodimer that binds to DNA ends with high 
affinity (Smider et al., 1994). Upon binding to DNA ends, the Ku heterodimer recruits 
DNA-PKcs to the sites of DSB (West et al., 1998). The DNA-PKcs protein becomes 
autophosphorylated and functions as a scaffold to bridge the broken DNA ends in a 
synaptic complex (DeFazio et al., 2002). The DNA-PKcs also provides binding sites 
for other NHEJ proteins such as nuclease Artemis (Ma et al., 2002), which is 
required for trimming of the DNA ends or XRCC4/DNAligase IV complex involved in 
re-joining step of NHEJ (O'Driscoll et al., 2001).   
 
The Artemis gene is also required for V(D)J recombination during T-cell and B-cell 
development. In order to get each V (D) J segments to join together the DNA must 
form a DSB. Also since the two ends of the broken DNA molecule generated by DSB 
are rarely compatible Artemis complexes with DNA-PKcs to create a hairpin opening 
which is one of the crucial stages of V(D)J recombination (Ma et al., 2002). 
 
Artemis deficiency in human subjects results in SCID which is characterised clinically 
by extreme radiosensitivity and by a complete absence of T and B cells due to a 
failure of the receptor recombination stage of V(D)J recombination (Dvorak and 
Cowan 2010). Attempts to correct the deficiency in cells by transduction with lentiviral 
gene expression vectors containing the Artemis cDNA has led to over-expression of 
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Artemis in a number of mammalian cell types (Multhaup et al., 2010). However, over-
expression has also resulted in a loss of cell viability, associated with increased DNA 
damage and elevated apoptosis as a result of abnormal activity of the Artemis 
endonuclease inducing DNA breaks (Multhaup et al., 2010).  
 
While such findings have significant implications for the role of gene therapy 
approaches for the treatment of SCID, it also reveals a potentially novel mechanism 
which may explain radiosensitivity in human cell types. To support this assertion, we 
have characterised two radiosensitive human fibroblast cell lines (175BR and 84BR) 
derived from different cancer patients in which we observed a two-fold increase in 
the expression of Artemis as determined by qRT-PCR analysis. This over-expression 
in Artemis was also associated with: 
 Enhanced cellular radiosensitivity (observed with clonogenic assays 
conducted with radiation). 
 A possible defect in NHEJ repair pathway (observed with clonogenic asays 
conducted with HN2). 
 A reduction in the repair of DNA DSBs (observed with H2AX DSB repair 
assay). 
 
Although, radiosensitivity is associated with deficiency in Artemis the study by 
Moshous et al., (2001) and by Multhaup et al., (2010) opted us to review the 
relationship between Artemis over-expression, DNA damage repair defect, 
radiosensitivity and apoptosis in radiosensitive human fibroblasts (84BR and 175BR).  
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5.2 - Materials and Method 
5.2.1- Transfection of NB1-Tert cells with Artemis cDNA   
The Artemis cDNA expression construct was purchased from Origene Inc (Rockville, 
MD, USA) which was provided in the expression plasmid pCMV6-XL5 (under control 
of the cytomegalovirus promoter). This plasmid was supplied without a selectable 
marker to identify transfected cells. Therefore the NB1-Tert cells were co-transfected 
with pCMV6-XL5 and pPur plasmid (Clontech, Hant, UK). 
 
Figure 5.1 -  Map of pCMV6-XL5.  
 
 
 
 
The pCMV-XL5 (4.5 kb) contains: a polylinker also known as the multiple cloning site (MCS), 
for cloning of the gene of interest; Cytomegalovirus (CMV), a promoter for the expression of 
cloned cDNA; an ampicillin-resistance gene (ampr), for selective amplification; the SV40 ori 
for replication in mammalian cells; f1 ori, the filamentous phage origin of replication, for 
recovery of single-stranded plasmids. 
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To overcome the absence of a selectable marker to identify Artemis transfected cells, 
the pCMV6-XL5 plasmid was co-transfected with the pPur plasmid shown below. The 
puromycin resistance gene was used as a selectable marker to identify the 
transfected cells. 
 
 
Figure 5.2- Map of Plasmid pPur. 
 
 
 
The 4.3 kb pPUR is a selection vector which contains; Puror gene that confers 
resistance to puromycin, pBR322 origin of replication for propagation in E.coli and 
Ampr gene for selection of transformed E.coli cells in cultures containing ampicillin. 
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5.2.2- Maxi Preparation of Plasmid DNA 
5.2.2.1 - Transformation of E.coli 
The pCMV6.XL5 plasmid containing the Artemis cDNA was transferred into 
chemically competent DH5α cells (Invitrogen, Paisley, Scotland) for amplification. 
Three µl (10ng) of plasmid was mixed in 100µl thawed DH5α competent bacteria 
cells, gently swirled and incubated on ice for 15 minutes. The bacterial cells were 
heat shocked at 42ºC for 2 minutes. One ml SOC medium was added to the mixture, 
mixed gently and transferred to a fresh Eppendorf tube. The SOC media was made 
by adding 20g of Bacto-tryptone, 5g of Bacto yeast extract, 2ml of 5M NaCI, 2.5ml of 
1M KCI, 10ml of 1M MgCI2, 10ml of 1M MgSO4, 20ml of 1M glucose added to 900ml 
of dH2O (all reagents purchased from Fisher Scientific). Once mixed, the volume was 
adjusted to 1L with dH2O and immediately autoclaved. Transformed E.coli were 
transferred to a sterile 15ml tube and incubated for 1 hour in 200rpm in the orbital 
incubator shaker (Gallenkamp, Holly, Misigan, USA) at 37ºC. After 1 hour incubation 
100µl and 200µl aliquots of the transformed sample were spread with a sterile 
spreader onto two separate pre made Luria-Bertani (LB) agar plates containing 
100µg/ml ampicillin. The plates were left to dry in sterile air under the flame of 
Bunsen burner. The plates were inverted in the incubator (Gallenkamp, Holly, 
Misigan, USA) at 37ºC for overnight incubation. The next day the bacteria growth 
was visible on the surface of the LB agar plates, the plates were either kept at 20ºC 
or a colony of bacteria was picked with a sterile loop and streaked in a fresh LB agar 
plate containing ampicillin and incubated further at 37ºC for overnight. This step was 
repeated three times for three days to get single small colonies. 
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5.2.2.2 -  Growing Large Volume of Transformed Bacteria 
Once single small colonies were achieved, the colonies were picked with a sterile 
loop in the centre to avoid picking satellites and inoculated in a 10ml LB culture 
medium containing 100µg/ml ampicillin. The transformed bacterial cells were 
incubated for 6-8 hours at 37ºC with vigorous shaking at 200rpm. The next day the 
bacteria culture became very turbid; this culture was re-inoculated in 1L of LB media 
and further incubated at 37ºC with vigorous shaking at 200rpm for overnight. One ml 
aliquots of cell culture in 80% glycerol were frozen at -80ºC.   
 
5.2.2.3 - Purification of Plasmid DNA 
Before commencing the maxi prep the RNAse was added to the P1 buffer then the 
P1 and the P3 buffers were stored at 4ºC until used. The following steps were then 
conducted using the QIAGEN plasmid maxi kit to extract the plasmid DNA from the 
bacteria culture.  
 
i. Bacteria culture, harvest and lysis  
The 1L of saturated bacterial culture grown in LB media was pelleted by 
centrifugation (Sigma 6k10, Meadowrose, UK) at 6000xg for 15 minutes at 4ºC. The 
bacterial pellet was homogenously re-suspended in 10ml re-suspension Buffer P1 
(100µg/ml RNase A, 50mM Tris-HCI and 10mM EDTA, pH 8) buffer. To the cells, 
10ml of lysis Buffer P2 (0.2 M NaOH in 1% SDS) was added then mixed vigorously 
by inverting for 4-6 times and incubated at RT for 5 minutes. To the viscous lysate 
10ml ice-cold Neutralisation Buffer P3 (2.55M potassium acetate, pH 4.8) was added 
to neutralise the lysing effect of Buffer P2, and, after thoroughly mixing the lysate 
was incubated on ice for 20 minutes.  
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ii. Bacterial lysate clearing      
The lysate was centrifuged at 16000 x g for 30 minutes at 4ºC then transferred to a 
fresh tube and re-centrifuged for 15 minutes to clear off any remaining pellet. The 
clear supernatant containing plasmid DNA was transferred to a fresh tube.  
 
iii. Bind, wash and elute plasmid DNA on QIAGEN-tip 
The QIAGEN tip was equilibrated by applying 10ml QBT Buffer (750mM NaCI, 50 
mM Mops, 15% ethanol and 0.15% Triton X-100, pH 7) and allowing the column to 
empty by gravity flow. The supernatant containing plasmid DNA was applied to the 
active QIAGEN tip and allowed to enter the resin by gravity flow. The QIAGEN tip 
was washed twice with 30ml of QC buffer (1M NaCI, 50mM Mops, 15% ethanol, pH 
7) by allowing the buffer run through the QIAGEN tip by gravity flow. The DNA was 
eluted with 15ml elution QF buffer (1.25M NaCI, 50mM Mops, 15% ethanol, pH 8.2) 
into a clean 50ml vessel.   
 
iv. Precipitate, wash and re-dissolve plasmid DNA  
The DNA was precipitated by adding 10.5ml RT isopropanol (0.7 volume of elution 
buffer) to the eluted DNA. The DNA was centrifuged at 16000 x g for 30 minutes at 
4ºC, and the supernatant was discarded. The DNA pellet was washed twice in 3ml 
RT 70% ethanol to remove the remaining salts from the preparation. The floating 
pellet was briefly spun at 13000 x g for 5 minutes, the methanol was discarded and 
the pellet was air dried for 5-10 minutes. The pellet was then re-dissolved in 750µl 
Tris-EDTA (TE) buffer (10mM Tris-CI (Sigma Aldrich, Germany) 1Mm EDTA (Fisher 
Scientific, New Jersey, USA) at pH 8.0. The DNA suspension was left at RT for few 
hours to allow the DNA to solubilise in TE buffer before storing at -20ºC. 
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5.2.3- Analysis of Purified Plasmid DNA 
The plasmid DNA was diluted in 1:100 (1µl DNA plus 99µl H2O) dilution and 1:10 
(10µl DNA plus 90µl H2O) dilution with DEPC treated water in two separate cuvettes. 
The UV spectrophotometer (Eppendorf, BioPhotometer) was turned on 15 minutes 
prior to use. The spectrophotometer was blanked with DEPC treated water. The 
concentration of the plasmid DNA was determined by measuring the absorbance at 
260nm (A260) on the spectrophotometer. An absorbance of 1 unit at 260nm 
corresponds to 50µg of DNA per ml. Therefore, the concentration of the purified 
plasmid DNA was calculated by using the following equation: 
 
DNA concentration (µg/ml) = (A260) x (dilution factor) x (50 µg/ml DNA) 
Total yield = DNA concentration x volume of sample in ml 
 
Then the purity of DNA was calculated by measuring the ratio between the 
absorbance values at 260 and 280 nm (260/280). 
 
5.2.4- Agarose Gel Analysis of Purified Plasmid DNA 
The purified plasmid DNA was run on a 1% agarose gel to assess the quality of the 
DNA and to confirm that the DNA sample is free from RNA contamination. The 
samples were run at 40V for 50 minutes, and visualised under UV transilluminator. 
An image of the DNA run was captured with the image acquisition end analysis 
system. 
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5.2.5- Co-transfection of NB1-Tert cells with pCMV6-XL5 Artemis cDNA  
Co-transfection of NB1-Tert cells with pCMV6-XL5 plasmid containing Artemis cDNA 
was performed with Genejuice lipid transfection reagent (Novagen, Ltd). Twenty 
micrograms of each plasmid in 100 l of serum free medium containing 3 l of 
Genejuice reagent was added to the 1X106 cells in 10ml of complete DMEM. The 
mixture was left on cells for 5 hours then the media was changed and the cells were 
incubated at 37ºC for 24 hours. The successfully transfected cells were selected in 
20 g/ml puromycin. The selection and medium refreshment were repeated once a 
week, for 4 weeks until distinct colonies were ready to be picked. A puromycin-
resistant clone was also isolated in which the cells were transfected with pPur only 
without pCMV6-XL5 plasmid.  
 
5.2.6- Isolation and Freezing of NB1-Tert Transfectants 
Puromycin resistant clones were collected by ring cloning and expanded into culture. 
The culture were transferred to 50mm Petri dishes containing 5ml complete medium 
supplemented with 20 g/ml puromycin and incubated at 37ºC in a humidified 
atmosphere of 10% CO2 in air. When cells reached to approximately 80% confluence 
aliquots of clones were frozen in liquid nitrogen for future use. When the puromycin 
resistant clones were subjected to further analysis an aliquot was gently thawed at 
37ºC prior to use.  
 
 
 
 
5.2.7- Clonogenic assay – Surviving fraction at 2 Gy gamma irradiation 
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The NB1-Tert cells and those transfected with the Artemis cDNA and pPur only were 
subjected to clonogenic assays to determine the -radiation sensitivity in each of the 
various clones selected. The procedure for clonogenic assay (see Chapter 3) was 
also employed here. The response of all five clones to -radiation was compared to 
that of non-transfected parental NB1-Tert cells.   
 
5.2.8- Quantitation of Artemis Protein Expression in Cells  
The Artemis protein expression in the fibroblast cell lines (NB1, 1BR.3, 84BR and 
175BR) and the NB1-Tert cell line transfected with Artemis was determined using the 
immunocytochemistry and imaging flow cytometry assay. Cells growing as 
monolayers were trypsinised and washed twice in 10ml of ice cold PBS. Following 
fixation in 3.7% paraformaldehyde in PBS at 4ºC for 15 minutes, cells were washed 
in PBS and fixed in 50:50 vol:vol methanol acetone for 10 minutes at 4ºC. Cells were 
rehydrated and permeabilised in tris buffered saline (TBS) containing 0.1% Tween 20 
after which the cells were stained with a rabbit polyclonal anti-artemis antibody at a 
dilution of 1/100 in permeabilisation buffer containing 5% goat serum (Abcam, 
Cambridge, UK). Following two washes in permeabilisation buffer, a goat anti-rabbit 
Alexa Fluor488 conjugated secondary antibody (Invitrogen) was added at a dilution of 
1/1000 for 1 hr at RT. Cells were washed three times in permeabilisation buffer and 
re-suspended in 100 l Accumax flow cytometry buffer (PAA Ltd.) containing 5 M 
Draq 5 (to visualise the nuclear region). Images of 10,000 cells were captured using 
the Imagestream and the level of Artemis expression in cells was determined by 
calculating the average Alexa Fluor488-associated fluorescence in the nuclei of the 
cells. 
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5.2.9- Apoptosis Assay 
The level of apoptosis in untreated and cells irradiated with 2Gy gamma radiation 
was determined by immunocytochemistry and imaging flow cytometry using a FITC 
Annexin-V Apoptosis detection kit (BD Pharmingen Ltd., Oxford, UK) according to 
the manufacturer’s instructions. In brief either untreated or cells irradiated with 2Gy 
gamma radiation were recovered into a suspension by trypsinisation and washed 
twice in PBS.  Cells were resuspended into 500 l of binding buffer to which was 
added 5 l annexin V-FITC and 5 l of propidium iodide. Cells were incubated for 10 
minutes at RT in the dark and levels of apoptosis were determined by counting 5,000 
cells using the Imagestream imaging flow cytometer with a 488nm laser at a power 
setting of 40m Watts (Amnis Corporation, Seattle, Washington, USA). Images of all 
cells were visualised using the Ideas™ analysis software programme of the 
Imagestream (Bourton et al., 2012). Here cells are first gated for single cells, cells in 
focus, followed by identification of apoptotic cells. Apoptotic cells were gated and 
enumerated by identifying those cells that exhibited FITC and propidium iodide 
staining. Staining patterns in all cells was visually confirmed by assessing the 
appearance of the cells using the Image Gallery of the Ideas  software package. 
 
5.2.10-  Sample loading and data analysis 
Levels of apoptosis were determined by counting 5,000 cells using the 
Imagestream  imaging flow cytometer with a 488nm laser at a power setting of 40m 
Watts (Amnis Corporation, Seattle, Washington, USA). Images of all cells were 
visualised using the Ideas™ analysis software programme of the Imagestream e.g. 
(Bourton et al., 2012). Here cells are first gated for single cells; cells in focus followed 
by cells that exhibit the following patterns of fluorescence. Early apoptotic cells were 
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gated and enumerated by identifying those cells that exhibited FITC fluorescence 
located at the membrane region of the cells. A membrane mask was created using 
the Mask Manager function of the Ideas  software. Late apoptotic cells were 
enumerated by gating those cells that exhibited both intracellular FITC and propidium 
iodide staining. Staining patterns in all cells was visually confirmed by assessing the 
appearance of the cells using the Image gallery of the Ideas  software package. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3 - Results 
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5.3.1 - Detection of plasmid Quality with Agarose gel  
The pPur and pCMV6-XL5 plasmids containing full length Artemis cDNA were 
amplified in E.coli and purified with Qiagen MaxiPrep kit. Once the plasmids were 
purified approximately 200 to 400ng of plasmids were run on a 1% agarose gel to 
detect the quality of the plasmids. The image Figure 5.3 illustrates the agarose gel 
analysis of pCMV6-XLF Artemis cDNA and pPUR plasmids. The pCMV6-XL5 
plasmid did not contain any selectable marker required for identification of 
transfected cells and isolation of the resulting colonies. To overcome this problem, 
the full length Artemis cDNA was co-transfected into recipient NB1-Tert cells with the 
pPur plasmid conferring resistance to puromycin. 
 
Figure 5.3 - Agarose gel analysis of the purified plasmids. 
 
 
 
 
The pPUR plasmid cDNA is 4.3 Kb and the pCMV6-XL5 plasmid containing full length 
Artemis cDNA is 4.5 Kb. The plasmids were purified using the Qiagen maxi columns and run 
on 1% agarose gel. 
5.3.2 - Artemis Expression in Cells 
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With the aid of pCMV6-XL5 and pPur plasmids the Artemis full length cDNA was 
transferred into NB1-Tert cells. In total six puromycin resistant clones were isolated. 
The level of Artemis expression in cells was measured by the method of imaging flow 
cytometry in conjunction with immunocytochemistry. Cells growing as monolayers 
were trypsinised and stained with antibodies to detect Artemis. Images of 10,000 
cells were captured with imaging flow cytometry and using a series of pre-determined 
analysis routines in the Ideas  software (Amnis Inc.) (e.g., Bourton et al., 2011) the 
average level of nuclear fluorescence attributable to Artemis expression was 
calculated. The data are summarised in Table 5.1. 
Table 5.1 - Artemis expression in all cell lines determined by imaging flow cytometry. 
Cell line Artemis Expression Cell line Artemis Expression 
 
NB1 
1.00 NB1-Tert 1.00 
 
1BR.3 
 
1.00 
Vector only 0.64 
 
84BR 
 
2.06 
Clone 1 1.81 
 
175BR 
 
2.09 
Clone 2 2.08 
  
Clone 3 1.65 
  
 
Clone 4 
 
2.02 
  
 
Clone 5 
 
2.25 
  
 
Clone 6 
 
 
1.05 
 
 
Artemis expression was determined by calculating the average Artemis associated 
fluorescence in the nuclei of 10,000 cell images. Artemis expression (fluorescence) 
in NB1-Tert parental cells or normal fibroblast cells is assigned a value of 1.0 
(relative fluorescence). Fluorescence in all other cell lines was expressed in relation 
to the relative fluorescence in normal cells or parental cells. 
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In the NB1 and 1BR.3 normal fibroblast cells the average nuclear fluorescence 
attributable to Artemis expression was averaged and given a value of 1.0. 
Expression of Artemis in the 84BR and 175BR was expressed in relation to levels in 
the normal fibroblast cells. We demonstrate that the 84BR and 175BR cells display a 
2.06 and 2.09-fold increase in nuclear Artemis expression. These data support our 
observations of elevated Artemis expression derived from the qRT-PCR 
experiments. 
 
Artemis expression in the NB1-Tert parental cells was derived as explained above. 
Artemis expression in the vector-only transfected cells and in clone 6 reveals a 
largely unchanged level of Artemis expression. However in clones 1-5 there is an 
increased level of Artemis expression in the nuclei of these cells. This ranged from a 
1.65-fold increased level of expression in clone 3 to a 2.25-fold elevated expression 
in clone 5. A representative image of Artemis staining of cells, derived from imaging 
flow cytometry is shown in Figure 5.4. 
 
 
Figure 5.4 - Representative images of NB1-Tert cells stained for Artemis. 
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A brightfield image is shown in the left column. The centre column shows Alexa Fluor488 
staining for Artemis and the right column shows the Draq 5 staining of the nuclear region of 
the cell. Row A shows NB1-Tert parental cells. Row B shows elevated Artemis expression in 
NB1-Tert clone 2 which has been transfected to over-express the Artemis protein.  
 
 
 
 
 
 
 
5.3.3 - Radiation Sensitivity of Artemis-Transfected NB1-Tert Cells 
Clonogenic cell survival in the Artemis-transfected NB1-Tert cells following exposure 
to 0, 2, 4, 6 and 8 Gy gamma radiation is shown in Figure 5.5. In the parental NB1-
Tert cells and those transfected with the pPur plasmid together with a single clone 
(clone 6) of Artemis transfected cells, there is a similar and normal level of survival. 
However, in NB1-Tert clones 1 to 5 (that are over-expressing Artemis), there is 
marked reduction in the clonogenic cell survival following exposure to increasing 
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doses of gamma radiation. In the single clone 6 in which the radiation response was 
unaltered, it is likely that here the cells were transfected with the pPur plasmid only 
and failed to acquire the Artemis gene during the co-transfection process. 
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Figure 5.5 - The -radiation sensitivity of Artemis transfectants. 
 
The survival of the NB1-Tert cells transfected with Artemis following exposure to 0, 2, 4, 6 
and 8 Gy gamma radiation. The NB1-Tert cells were transformed with Artemis cDNA and the 
transfected clones as well as non-transfected clones were diluted and irradiated with 
different doses of -radiation, as explained in Chapter 1. Surviving colonies were then fixed, 
stained and colonies counting 50 or more were counted. Survival of each clones were 
normalised to plating efficiency of unirradiated control cells. Data are derived from three 
independent experiments and error bars shown represent standard error of the mean. The P 
value is <0.05. 
 
 
 
 
 
 
 
5.3.4 - Elevated Apoptosis in Artemis-Transfected NB1-Tert Cells 
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Apoptosis in NB1-Tert cells transfected to over-express Artemis was measured by 
imaging flow cytometry. In five of six clones we demonstrated a significantly 
increased level of apoptosis when compared to non-transfected cells and cells 
transfected with the pPur vector only. In clone 6 we did not observe elevated 
apoptosis. Interestingly, this clone was not observed to have elevated Artemis 
expression; this is likely due to the failure to transfect with the Artemis cDNA during 
co-transfection. 
 
 
Figure 5.6 - Apoptosis in NB1-Tert cells transfected to over-express the Artemis 
protein. 
 
 
Data are derived from analysing the images of not less than 5000 cells. Standard deviation 
bars are included and shown on the graph. White bars are untreated cells. Grey bars are 
cells treated with a 2 Gy gamma radiation. The P value is < 0.05. 
 
 
Figure 5.7- Non-apoptotic and cells at different stages of apoptosis. 
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Images derived from Imagestream analysis shows a brightfield image together with an image 
of Annexin V staining (FITC) and an image of the nucleus stained with PI. A: A normal cell 
with spherical nucleous and no sign of apoptosis, B: Shrunken cell with light fluorescence as 
a sign of early apoptosis, C: cell beginning to bleb and intense green fluorescence indicates 
apoptosis, D: Cell membrane breaking and intense fluorescence indicating high level of 
apoptosis. 
 
 
 
 
 
 
5.3.5 - Apoptosis in radiation hypersensitive patient cells  
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The data in Figure 5.6 shows that in the repair normal NB1 and 1BR.3 cells the 
levels of apoptosis in un-irradiated cells (determined by the number of cells positive 
for Annexin V and propidium iodide staining) is 5.00% and 3.31% of all cells. 
Following 2 Gy gamma radiation the levels of radiation-induced apoptosis increases 
to 8.65% and 11.50% respectively for each cell line. In the radiation-sensitive 84BR 
and 175BR fibroblasts, apoptosis levels in un-irradiated cells are 8.65% and 10.32% 
respectively. Following 2Gy irradiation these levels increase to 24.54% and 30.60% 
respectively. These data indicate that spontaneous levels of apoptosis in the 
radiosensitive cell lines are higher than in the repair-competent NB1 and 1BR.3 cells. 
Moreover, a similar and significantly increased level of apoptosis is observed in the 
84BR and 175BR cell lines compared to the repair competent fibroblasts (P < 0.05, 
Student’s unpaired t-test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 - Apoptosis in patient and in control cells. 
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Here the apoptosis level in NB1 and 1BR.3 repair normal cell lines compared with the 
radiosensitive 84BR and 175BR cell lines prior (white bars) and following 2Gy gamma 
radiation (grey bars) is illustrated. Apoptosis was determined by Annexin V and propidium 
iodide staining and data are derived from imaging flow cytometry using the Imagestream 
whereby images of 5000 or more cells were captured and apoptotic cells determined. 
Standard deviation bars are included and shown on the graphs. The P value is < 0.05. 
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5.4 - Discussion 
In previous chapters, it was demonstrated that the 84BR and 175BR patient cell lines 
were hypersensitive to the lethal effects of -radiation. However, a normal response 
to DNA cross-linking agent (nitrogen mustard), as explained in Chapter 3, which 
requires collaboration of NHEJ and HR, indicated that the likely defective pathway 
controlling the hypersensitivity was NHEJ. The qRT-PCR analysis of key genes 
associated with NHEJ DNA repair revealed a 1.5-2 fold over-expression of the 
Artemis endonuclease in both 175BR and 84BR patient cells. Thus, the likelihood of 
radiosensitivity as a result of Artemis over expression in these cells. To investigate 
further this hypothesis and subsequently to reveal the defect in Artemis gene, the 
NB1-Tert cells were co-transfected with full length Artemis cDNA. The pCMV6.XL5 
vector did not carry any selectable marker, thus the full length Artemis cDNA was co-
transfected with plasmid pPur into NB1-Tert cells and the transfectant capable of 
growing and producing clones in puromycin were isolated. In total six clones were 
identified. The use of imaging flow cytometry revealed the highest Artemis 
expression, ranging between 1.65 to 2.25 fold, in clones 1-5, while in clone 6  there 
was largely unchanged level of Artemis expression. It is likely that the clone 6 was 
co-transfected with pPur only thus the reason why the Artemis expression was 
largely unchanged.  
 
The radiosensitivity of these clones was examined through -irradiation clonogenic 
assay. Different clones containing Artemis cDNA were irradiated with increasing 
doses of -irradiation. Non-transfected NB1-Tert cell line served as control in this 
experiment. The -irradiation survival curve showed that the NB1-Tert clones 1 to 5 
had a marked reduction in the clonogenic cell survival following exposure to 
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increasing doses of gamma radiation, suggesting that the radiosensitivity in these 
clones may be associated with the over-expression of Artemis gene. Thus, further 
supporting the association of high Artemis expression detected in Chapter 4 with 
qRT-PCR, with radiosensitivity in175BR and 84BR patients.  
 
One explanation as to why those cells with high expression of Artemis, (the five NB1-
Tert clones and the two patient cell lines (175BR and 84BR) displayed much higher 
cellular radiosensitivity in comparison to the controls, might be due to the fact that the 
more Artemis is being made, the higher is the nuclease activity (i.e. the trimming of 
the DNA ends) during the NHEJ repair of DSBs of DNA. Therefore, as the nuclease 
activity increases more DNA is un-specifically trimmed and less XRCC4 and Ligase 
IV proteins are available for the ligation and sealing of the DNA ends. The un-specific 
cutting of the DNA therefore, resulted in a defect in the ability of both patient cells to 
repair the DSBs caused by IR. This may then have resulted in high sensitivity to 
radiation in cells with high expression of Artemis. 
 
While we demonstrate radiosensitivity associated with Artemis over-expression in the 
two cell lines and that this result is concordant with that of (Multhaup et al., 2010), 
others have not demonstrated similar findings. For example, over-expression of 
functional Artemis in the 48BR normal fibroblast cell line results in increased 
radioresistance. However an Artemis construct deleted at the C-terminus thus 
removing endonuclease activity of the protein results in a dominant negative 
phenotype whereby the 48BR fibroblasts are rendered sensitive to the lethal effects 
of radiation and radiomimetic drugs (Mohapatra et al., 2011). The apparent disparity 
of these findings are unclear but it may be speculated that cell line specific 
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differences in DNA repair and gene expression may underpin the differences in 
radiation survival following Artemis transfection. Alternatively, over-expression of an 
endonuclease such as Artemis beyond a critical level may lead to cytotoxicity rather 
than resistance to radiation. 
 
Also in five of six clones and the two radiation-sensitive fibroblasts (84BR and 
175BR) the apoptosis was elevated after gamma radiation exposure. Thus, the data 
indicate that the spontaneous levels of apoptosis in the radiosensitive cell lines are 
higher than in the repair-competent NB1, 1BR.3  and NB1-Tert cells.  
 
To reiterate, our findings together with the results of others (e.g. Mohapatra et al., 
2011) indicate that both increased and reduced levels of Artemis expression can 
result in cellular radiosensitivity. While the level of over-expression in the 84BR and 
175BR cell lines is approximately 1.5-2 fold, we do observe elevated apoptosis and a 
failure to efficiently repair DNA DSB before and following radiation exposure.  
Therefore, we hypothesise that the increased expression of the Artemis protein 
appears to act in a dominant negative manner and can result in elevated sensitivity 
to IR and elevated apoptosis. 
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Chapter 6 - General Discussion 
 
In this research, the cellular radiosensitivity in two human fibroblast cell lines (84BR 
and 175BR) has been identified. The 84BR fibroblast cell line was derived from a 
non-affected skin biopsy of radiosensitive breast cancer patient (Arlett et al., 1989). 
The 175BR cell line as derived from a non-affected skin biopsy from an individual 
with multiple tumours of independent histological origin and was a kind gift from 
Professor Bruce Ponder (Cambridge Research Institute, Cambridge, UK). 
 
The breast cancer patient is an adult female who has over-reacted to radiotherapy. 
Also on the RTOG scale this patient was categorised as class three patient with 
severe odema, swelling and persistent fibrosis (Cox et al., 1995). The clinical hyper 
sensitivity to radiotherapy in 84BR patient was also confirmed at cellular level by two 
independent studies conducted by Arlett et al., (1989) and Alsbeih et al., (1996). 
 
According to the family pedigree, provided by Professor Bruce Ponder, and the 
patient information provided by Dr C.F Arlett, the patient 175BR is an adult male and 
multiple tumours existed amongst other members of his family. However, there is no 
evidence of clinical radiosensitivity and over-reaction to radiotherapy in this patient.  
 
Other cell lines used in this project were the NB1 and 1.BR3 normal diploid fibroblast 
cell lines as described in Bridger and Kill (2004) and Arlett et al., 1988 and the 
immortal NB1-Tert cell line was established during this research.   
 
The clonogenic assays were conducted by exposure of cells to IR and the DNA 
cross-linking agent (nitrogen mustard). The clonogenic assay conducted with IR had 
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two fold purposes; to detect the hypersensitivity of both patient cells to -radiation, 
and to confirm the findings of Arlett et al., (1989) and Alsbeih et al., (1996) which 
supports the radiosensitivity of 84BR patient cells at cellular level. The results of 
clonogenic assay with IR demonstrated that both the 84BR and 175BR patient cells 
were 1.5-2 fold more sensitive to the lethal effects of IR, than two fibroblast cell lines 
1BR.3 and NB1 derived from repair normal individuals.   
 
The exposure of cells to -radiation can result in single strand breaks single strand 
breaks together with sugar and base oxidations. The damage to DNA is recognised 
and repaired by specific DNA repair pathways. The three enzymatically distinct 
pathways that repair DNA DSBs are: NHEJ, HR, and SSA. While the NHEJ is the 
main pathway of IR-induced DSB repair in eukaryotic cells the HR is the principle 
mechanism in prokaryotic cells.  
 
To determine the defective DSB repair pathway responsible for -radiation sensitivity 
of 84BR and 175BR cell lines, these cells were treated with increasing doses of HN2. 
As exposure of HN2 on patient cells revealed similar response to that of control cells, 
the possibility of defective HR was excluded thus, the results implied a defect in 
NHEJ pathway.   
 
The DSBs in 84BR and 175BR cells were detected by immunofluorescence assay 
where the cells treated with -irradiation and the ability of the cells to repair DSBs 
were measured with anti -H2AX antibody. The DSB repair in these cells were 
measured on the basis of clearance of -H2AX foci against repair time and compared 
to that of control cell lines. Immunofluorescence assay showed that in 84BR and 
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175BR cells the majority of the -H2AX foci were still present after 24 hour exposure 
to IR, which suggested defective DSB repair. The majority of -H2AX foci in control 
cell lines (NB1 and 1.BR3) were cleared thus, indicated the efficient repair of DSBs. 
The persistence of -H2AX foci even at 24hr post irradiation in patient cells and 
enhanced radiosensitivity in patient cell lines was associated with a failure to 
effectively repair DNA DSBs following radiation exposure.   
 
The next step of this research involved detection of NHEJ repair defect which may 
have been responsible for the radiosensitivity seen in both patients. To identify the 
NHEJ defective gene the qRT-PCR assay was conducted. This assay enabled us to 
study the level of gene expression of some of the key genes (Ku70, Ku80, DNAPKcs, 
XRCC4, XLF, Ligase IV and Artemis) found in NHEJ repair pathway. Quantitative 
PCR analysis of key genes associated with NHEJ DNA repair revealed a 1.5-2 fold 
over-expression of the Artemis endonuclease, which is a key component of the 
NHEJ repair pathway. In the absence of detecting any other defect in the cells other 
than an abnormal over-expression of Artemis, it was necessary to determine how 
such a phenotype might be responsible for the radiation hypersensitivity of the two 
cell lines 
 
A study by Multhaup et al., (2010) investigating the use of lentivral vectors for the 
gene therapy of RS-SCID demonstrated that over-expression of the Artemis protein 
was associated with reduced cell survival, increased DNA damage and elevated 
apoptosis. Similarly, we hypothesised from our observations that in the cell lines 
described in this study, that increased expression of the Artemis endonuclease might 
be acting as a dominant negative leading to abnormal and illegitimate DNA DSBs 
139 
 
due to the unregulated action of the protein thus contributing to increased 
radiosensitivity. 
 
The expression of Artemis protein in fibroblast cell lines (NB1, 1BR.3, 84BR and 
175BR) and clones of NB1.Tert cells transfected with Artemis was determined using 
immunocytochemistry and imaging flow cytometry. A 2.06 and 2.09-fold increase in 
nuclear Artemis was detected thus, confirming the observations of elevated Artemis 
expression detected by RT-qPCR experiments. Also the Artemis expression ranged 
from 1.65-fold increased level in clone 3 to 2.25-fold elevated expression in clone 5.  
 
As in Multhaup et al., (2010) study to determine the effect of over-expression of 
Artemis in those fibroblast cells the apoptosis assay was conducted. The levels of 
apoptosis in untreated and cells irradiated with 2Gy gamma radiation were 
determined by immunocytochemistry and imaging flow cytometry. In the repair 
normal NB1 and 1BR.3 cells the levels of apoptosis in un-irradiated cells was 5.00% 
and 3.31% of all cells. After treating the cells to 2Gy gamma radiation the levels of 
radiation induced apoptosis increased to 8.65% and 11.50% respectively for each 
cell line. In the radiation-sensitive 84BR and 175BR fibroblasts, apoptosis levels in 
un-irradiated cells were 8.65% and 10.32% respectively. Following 2Gy irradiation 
these levels increased to 24.54% and 30.60% respectively. Thus the results indicate 
a much higher spontaneous levels of apoptosis in the radiosensitive cell lines when 
compared to repair-component NB1 and 1BR.3 cell lines.  
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Similarly the apoptosis in NB1-Tert cells transfected to over-express Artemis was 
also significantly increased when compared to non-transfected cells and cells 
transfected with the pPur vector only. 
 
The clonogenic cell survival in the Artemis transfected NB1-Tert clones 1 to 5 (that 
are over-expressing Artemis), a marked reduction in the clonogenic cell survival was 
also confirmed following exposure to increasing doses of gamma radiation.  
 
Thus, the increased endonuclease activity associated with over-expression of 
Artemis is associated with higher levels of DNA DSB, radiosensitivity and elevated 
apoptosis in two radio-hypersensitive cell lines (175BR and 84BR) as well as those 
NB1-Tert clones 1 to 5 with high expression of Artemis. These data reveal a 
potentially novel mechanism responsible for radiosensitivity in human cells. 
 
From these observations we propose a novel mechanism of cellular radiation 
hypersensitivity whereby the increased expression of the Artemis endonuclease 
promotes illegitimate DNA DSB leading to elevated DNA damage and elevated 
apoptosis associated with clinical and cellular radiosensitivity. Also the prolonged 
H2AX foci in patient cells are not only due to deficiency in repairing DSBs. Also the 
foci may be the result of new breaks being created due to an excess of the Artemis 
nuclease.  
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Future Work  
Since the over-expression of Artemis resulted in radiosensitivity in two patient cell 
lines (84BR and 175BR) and in NB1-Tert cells transfected to induce high expression 
of Artemis in clonogenic assay the gene knockdown would ideally bring the level of 
Artemis expression to a normal level. One suggestion is that normal level of Artemis 
expression may restore normal radiosensitivity in the cells. Thus, a restoration of 
normal radiosensitivity might lead to efficient DSB repair and automatically a 
reduction in apoptosis levels in those cells.  
 
Also, it would be interesting to see if over-expression of Artemis in DNA-PKcs 
defective cells would cause radiosensitivity as described in this thesis. The cell lines 
XP14BRneo17 (Abbaszadeh et al., 2010) and the MO59J (Anderson et al., 2001) are 
defective in DNA-PKcs. Therefore, over-expression of Artemis in these cell lines may 
not render the cells sensitive to radiation due to the necessity for DNA-PKcs 
phosphorylation of Artemis. This would also address this question as to whether 
other kinases have the ability to activate Artemis in the absence of DNA-PKcs. 
 
Finally, we have demonstrated a dominant negative effect of Artemis over-
expression in two fibroblast cell lines derived from cancer patient and in the cell line 
NB1-Tert transfected to over-express Artemis. It may be conceded that this is a 
limited number of cell types. Therefore, it would be a useful enterprise to determine 
the effect in a wider variety of cell types from normal individuals and in cells derived 
from different types of cancer. Moreover, the critical level of Artemis expression in 
cells which results in radiosensitivity needs to be addressed. For example, it was 
demonstrated that a twofold over-expression of Artemis results in radiosensitivity. It 
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would be useful to create a range of cell lines with increasing and decreasing levels 
of Artemis to determine which level of protein expression induces radiation 
resistance and sensitivity. 
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